BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: van Gijn W, Marijnen CA, Nagtegaal ID, Kranenbarg EM, Putter H, Wiggers T, Rutten HJ, Påhlman L, Glimelius B, van de Velde CJ; Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer: 12-year follow-up of the multicentre, randomised controlled TME trial. Lancet Oncol 2011;12:575-82. [PMID: 21596621 DOI: 10.1016/S1470-2045(11)70097-3] [Cited by in Crossref: 974] [Cited by in F6Publishing: 353] [Article Influence: 97.4] [Reference Citation Analysis]
Number Citing Articles
1 Peltrini R, Luglio G, Cassese G, Amendola A, Caruso E, Sacco M, Pagano G, Sollazzo V, Tufano A, Giglio MC, Bucci L, Palma GD. Oncological Outcomes and Quality of Life After Rectal Cancer Surgery.Open Med (Wars). 2019;14:653-662. [PMID: 31565674 DOI: 10.1515/med-2019-0075] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
2 Cassidy RJ, Switchenko JM, Cheng E, Jiang R, Jhaveri J, Patel KR, Tanenbaum DG, Russell MC, Steuer CE, Gillespie TW, McDonald MW, Landry JC. Health care disparities among octogenarians and nonagenarians with stage II and III rectal cancer. Cancer 2017;123:4325-36. [PMID: 28759121 DOI: 10.1002/cncr.30896] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.0] [Reference Citation Analysis]
3 Hardiman KM, Ulintz PJ, Kuick RD, Hovelson DH, Gates CM, Bhasi A, Rodrigues Grant A, Liu J, Cani AK, Greenson JK, Tomlins SA, Fearon ER. Intra-tumor genetic heterogeneity in rectal cancer. Lab Invest 2016;96:4-15. [PMID: 26568296 DOI: 10.1038/labinvest.2015.131] [Cited by in Crossref: 47] [Cited by in F6Publishing: 50] [Article Influence: 7.8] [Reference Citation Analysis]
4 Sato H, Shimada M, Kurita N, Iwata T, Yoshikawa K, Higashigima J, Chikakio M, Kashihara H, Takasu C, Matsumoto N, Eto S. Phase I trial of neoadjuvant preoperative chemotherapy with S-1, oxaliplatin, and bevacizumab plus radiation in patients with locally advanced rectal cancer. Int J Clin Oncol 2015;20:543-8. [PMID: 25080061 DOI: 10.1007/s10147-014-0733-z] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
5 Huang WS, Kuan FC, Lin MH, Chen MF, Chen WC. Prognostic Significance of Neoadjuvant Rectal Scores in Preoperative Short-Course Radiotherapy and Long-Course Concurrent Chemoradiotherapy for Patients with Locally Advanced Rectal Cancer. Ann Surg Oncol 2020;27:4309-18. [PMID: 32794029 DOI: 10.1245/s10434-020-09018-z] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
6 Yoo RN, Kim HJ. Organ Preservation Strategies After Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer.Ann Coloproctol. 2019;35:53-64. [PMID: 31113170 DOI: 10.3393/ac.2019.04.15.1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
7 Watanabe T, Hata K. Robotic surgery for rectal cancer with lateral lymph node dissection. Br J Surg 2016;103:1755-7. [PMID: 27901281 DOI: 10.1002/bjs.10412] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.3] [Reference Citation Analysis]
8 Omidvari S, Zohourinia S, Ansari M, Ghahramani L, Zare-Bandamiri M, Mosalaei A, Ahmadloo N, Pourahmad S, Nasrolahi H, Hamedi SH, Mohammadianpanah M. Efficacy and Safety of Low-Dose-Rate Endorectal Brachytherapy as a Boost to Neoadjuvant Chemoradiation in the Treatment of Locally Advanced Distal Rectal Cancer: A Phase-II Clinical Trial. Ann Coloproctol 2015;31:123-30. [PMID: 26361613 DOI: 10.3393/ac.2015.31.4.123] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
9 Yeo SG, Kim MJ, Kim DY, Chang HJ, Kim MJ, Baek JY, Kim SY, Kim TH, Park JW, Oh JH. Patterns of failure in patients with locally advanced rectal cancer receiving pre-operative or post-operative chemoradiotherapy. Radiat Oncol 2013;8:114. [PMID: 23647920 DOI: 10.1186/1748-717X-8-114] [Cited by in Crossref: 21] [Cited by in F6Publishing: 10] [Article Influence: 2.6] [Reference Citation Analysis]
10 Liu Z, Meng X, Zhang H, Li Z, Liu J, Sun K, Meng Y, Dai W, Xie P, Ding Y, Wang M, Cai G, Tian J. Predicting distant metastasis and chemotherapy benefit in locally advanced rectal cancer. Nat Commun. 2020;11:4308. [PMID: 32855399 DOI: 10.1038/s41467-020-18162-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 7] [Article Influence: 9.0] [Reference Citation Analysis]
11 Nardone V, Reginelli A, Scala F, Carbone SF, Mazzei MA, Sebaste L, Carfagno T, Battaglia G, Pastina P, Correale P, Tini P, Pellino G, Cappabianca S, Pirtoli L. Magnetic-Resonance-Imaging Texture Analysis Predicts Early Progression in Rectal Cancer Patients Undergoing Neoadjuvant Chemoradiation. Gastroenterol Res Pract 2019;2019:8505798. [PMID: 30847005 DOI: 10.1155/2019/8505798] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 6.0] [Reference Citation Analysis]
12 Zhang Y, Yan L, Wu Y, Xu M, Liu X, Guan G. Worse treatment response to neoadjuvant chemoradiotherapy in young patients with locally advanced rectal cancer. BMC Cancer 2020;20:854. [PMID: 32891131 DOI: 10.1186/s12885-020-07359-2] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
13 Holmqvist A, Gao J, Holmlund B, Adell G, Carstensen J, Langford D, Sun XF. PINCH is an independent prognostic factor in rectal cancer patients without preoperative radiotherapy--a study in a Swedish rectal cancer trial of preoperative radiotherapy. BMC Cancer 2012;12:65. [PMID: 22325464 DOI: 10.1186/1471-2407-12-65] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
14 Song SB, Wu GJ, Pan HD, Yang H, Hu ML, Li Q, Yan QX, Xiao G. The quality of total mesorectal excision specimen: A review of its macroscopic assessment and prognostic significance. Chronic Dis Transl Med 2018;4:51-8. [PMID: 29756123 DOI: 10.1016/j.cdtm.2018.02.002] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
15 Guckenberger M, Saur G, Wehner D, Sweeney RA, Thalheimer A, Germer CT, Flentje M. Comparison of preoperative short-course radiotherapy and long-course radiochemotherapy for locally advanced rectal cancer. Strahlenther Onkol 2012;188:551-7. [PMID: 22638934 DOI: 10.1007/s00066-012-0131-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 1.4] [Reference Citation Analysis]
16 Kim TH, Woo S, Han S, Suh CH, Vargas HA. The Diagnostic Performance of MRI for Detection of Extramural Venous Invasion in Colorectal Cancer: A Systematic Review and Meta-Analysis of the Literature.AJR Am J Roentgenol. 2019;213:575-585. [PMID: 31063424 DOI: 10.2214/AJR.19.21112] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
17 Bird TG, Ngan SY, Chu J, Kroon R, Lynch AC, Heriot AG. Outcomes and prognostic factors of multimodality treatment for locally recurrent rectal cancer with curative intent. Int J Colorectal Dis 2018;33:393-401. [PMID: 29468354 DOI: 10.1007/s00384-018-2985-y] [Cited by in Crossref: 13] [Cited by in F6Publishing: 9] [Article Influence: 4.3] [Reference Citation Analysis]
18 Zhang JW, Cai Y, Xie XY, Hu HB, Ling JY, Wu ZH, Lan P, Wu XJ, Huang MJ, Wang H, Kang L, Zhou ZY, Wang JP, Deng YH. Nomogram for predicting pathological complete response and tumor downstaging in patients with locally advanced rectal cancer on the basis of a randomized clinical trial. Gastroenterol Rep (Oxf) 2020;8:234-41. [PMID: 32665855 DOI: 10.1093/gastro/goz073] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
19 Kim NK, Kim MS, Al-Asari SF. Update and debate issues in surgical treatment of middle and low rectal cancer. J Korean Soc Coloproctol 2012;28:230-40. [PMID: 23185702 DOI: 10.3393/jksc.2012.28.5.230] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
20 Russell MC, You YN, Hu CY, Cormier JN, Feig BW, Skibber JM, Rodriguez-Bigas MA, Nelson H, Chang GJ. A novel risk-adjusted nomogram for rectal cancer surgery outcomes. JAMA Surg. 2013;148:769-777. [PMID: 23803722 DOI: 10.1001/jamasurg.2013.2136] [Cited by in Crossref: 40] [Cited by in F6Publishing: 39] [Article Influence: 5.0] [Reference Citation Analysis]
21 Yun JA, Huh JW, Kim HC, Park YA, Cho YB, Yun SH, Lee WY, Chun HK. Local recurrence after curative resection for rectal carcinoma: The role of surgical resection. Medicine (Baltimore). 2016;95:e3942. [PMID: 27399067 DOI: 10.1097/md.0000000000003942] [Cited by in Crossref: 19] [Cited by in F6Publishing: 8] [Article Influence: 4.8] [Reference Citation Analysis]
22 Denost Q, Saillour F, Masya L, Martinaud HM, Guillon S, Kret M, Rullier E, Quintard B, Solomon M. Benchmarking trial between France and Australia comparing management of primary rectal cancer beyond TME and locally recurrent rectal cancer (PelviCare Trial): rationale and design. BMC Cancer 2016;16:262. [PMID: 27044252 DOI: 10.1186/s12885-016-2286-1] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 0.8] [Reference Citation Analysis]
23 Ryan ÉJ, Creavin B, Sheahan K. Delivery of Personalized Care for Locally Advanced Rectal Cancer: Incorporating Pathological, Molecular Genetic, and Immunological Biomarkers Into the Multimodal Paradigm. Front Oncol 2020;10:1369. [PMID: 32923389 DOI: 10.3389/fonc.2020.01369] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
24 Su M, Zhu LC, Wei HP, Luo WH, Lin RF, Zou CL. S-1-Based versus capecitabine-based preoperative chemoradiotherapy in the treatment of locally advanced rectal cancer: a matched-pair analysis. PLoS One 2014;9:e106162. [PMID: 25181318 DOI: 10.1371/journal.pone.0106162] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
25 Rigter LS, Rijkmans EC, Inderson A, van den Ende RPJ, Kerkhof EM, Ketelaars M, van Dieren J, Veenendaal RA, van Triest B, Marijnen CAM, van der Heide UA, van Leerdam ME. EUS-guided fiducial marker placement for radiotherapy in rectal cancer: feasibility of two placement strategies and four fiducial types. Endosc Int Open 2019;7:E1357-64. [PMID: 31673605 DOI: 10.1055/a-0958-2148] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
26 Boland PM, Fakih M. The emerging role of neoadjuvant chemotherapy for rectal cancer. J Gastrointest Oncol. 2014;5:362-373. [PMID: 25276409 DOI: 10.3978/j.issn.2078-6891.2014.060] [Cited by in F6Publishing: 9] [Reference Citation Analysis]
27 Amano K, Fukuchi M, Kumamoto K, Hatano S, Ohno H, Osada H, Ishibashi K, Ishida H. Pre-operative Evaluation of Lateral Pelvic Lymph Node Metastasis in Lower Rectal Cancer: Comparison of Three Different Imaging Modalities. J Anus Rectum Colon 2020;4:34-40. [PMID: 32002474 DOI: 10.23922/jarc.2019-022] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
28 Kazi M, Sukumar V, Desouza A, Saklani A. State-of-the-art surgery for recurrent and locally advanced rectal cancers. Langenbecks Arch Surg 2021. [PMID: 34341869 DOI: 10.1007/s00423-021-02285-8] [Reference Citation Analysis]
29 Vermeer TA, Orsini RG, Rutten HJ. Surgery for rectal cancer-what is on the horizon? Curr Oncol Rep 2014;16:372. [PMID: 24488545 DOI: 10.1007/s11912-013-0372-y] [Cited by in Crossref: 2] [Article Influence: 0.3] [Reference Citation Analysis]
30 Feng S, Yan P, Zhang Q, Li Z, Li C, Geng Y, Wang L, Zhao X, Yang Z, Cai H, Wang X. Induction chemotherapy followed by neoadjuvant chemoradiotherapy and surgery for patients with locally advanced rectal cancer: a systematic review and meta-analysis. Int J Colorectal Dis 2020;35:1355-69. [PMID: 32488419 DOI: 10.1007/s00384-020-03621-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
31 He F, Yu L, Ding Y, Li ZH, Wang J, Zheng J, Chen HY, Liu S, Pang XL, Ajani JA, Wan XB. Effects of neoadjuvant chemotherapy with or without intensity-modulated radiotherapy for patients with rectal cancer.Cancer Sci. 2020;111:4205-4217. [PMID: 32860448 DOI: 10.1111/cas.14636] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
32 Ha GW, Lee MR. Oncologic effects of adjuvant chemotherapy in patients with ypT0-2N0 rectal cancer after neoadjuvant chemoradiotherapy and curative surgery: a meta-analysis. Ann Surg Treat Res 2020;99:97-109. [PMID: 32802815 DOI: 10.4174/astr.2020.99.2.97] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
33 Lu NN, Jin J, Wang SL, Wang WH, Song YW, Liu YP, Ren H, Fang H, Liu XF, Yu ZH, Li YX. Postoperative Capecitabine with Concurrent Intensity-Modulated Radiotherapy or Three-Dimensional Conformal Radiotherapy for Patients with Stage II and III Rectal Cancer. PLoS One 2015;10:e0124601. [PMID: 25915948 DOI: 10.1371/journal.pone.0124601] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
34 Goossens-Beumer IJ, Oosting J, Corver WE, Janssen MJ, Janssen B, van Workum W, Zeestraten EC, van de Velde CJ, Morreau H, Kuppen PJ, van Wezel T. Copy number alterations and allelic ratio in relation to recurrence of rectal cancer. BMC Genomics 2015;16:438. [PMID: 26048403 DOI: 10.1186/s12864-015-1550-0] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
35 Cellini F, Arcelli A, Simoni N, Caravatta L, Buwenge M, Calabrese A, Brunetti O, Genovesi D, Mazzarotto R, Deodato F, Mattiucci GC, Silvestris N, Valentini V, Morganti AG. Basics and Frontiers on Pancreatic Cancer for Radiation Oncology: Target Delineation, SBRT, SIB technique, MRgRT, Particle Therapy, Immunotherapy and Clinical Guidelines. Cancers (Basel). 2020;12. [PMID: 32610592 DOI: 10.3390/cancers12071729] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 7.0] [Reference Citation Analysis]
36 Butiurca VO, Molnar C, Copotoiu C, Botoncea M, Bud TI, Kovacs Z, Satala C, Gurzu S. Long Term Results of Modified Intersphincteric Resections for Low Rectal Cancer: A Single Center Experience. Medicina (Kaunas) 2019;55:E764. [PMID: 31795439 DOI: 10.3390/medicina55120764] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
37 Ohue M, Iwasa S, Kanemitsu Y, Hamaguchi T, Shiozawa M, Ito M, Yasui M, Katayama H, Mizusawa J, Shimada Y; Colorectal Cancer Study Group/Japan Clinical Oncology Group. A Phase II/III randomized controlled trial comparing perioperative versus postoperative chemotherapy with mFOLFOX6 for lower rectal cancer with suspected lateral pelvic node metastasis: Japan Clinical Oncology Group Study JCOG1310 (PRECIOUS study). Jpn J Clin Oncol 2017;47:84-7. [PMID: 27655905 DOI: 10.1093/jjco/hyw140] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.4] [Reference Citation Analysis]
38 Martin-Gonzalez P, de Mariscal EG, Martino ME, Gordaliza PM, Peligros I, Carreras JL, Calvo FA, Pascau J, Desco M, Muñoz-Barrutia A. Association of visual and quantitative heterogeneity of 18F-FDG PET images with treatment response in locally advanced rectal cancer: A feasibility study. PLoS One 2020;15:e0242597. [PMID: 33253194 DOI: 10.1371/journal.pone.0242597] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
39 Hossain MS, Quadery Tonmoy MI, Islam MN, Islam MS, Afif IK, Singha Roy A, Fariha A, Al Reza H, Bahadur NM, Rahaman MM. MicroRNAs expression analysis shows key affirmation of Synaptopodin-2 as a novel prognostic and therapeutic biomarker for colorectal and cervical cancers. Heliyon 2021;7:e07347. [PMID: 34195444 DOI: 10.1016/j.heliyon.2021.e07347] [Reference Citation Analysis]
40 Jia AY, Narang A, Safar B, Zaheer A, Murphy A, Azad NS, Gearhart S, Fang S, Efron J, Warczynski T, Hacker-Prietz A, Meyer J. Sequential short-course radiation therapy and chemotherapy in the neoadjuvant treatment of rectal adenocarcinoma. Radiat Oncol 2019;14:147. [PMID: 31426827 DOI: 10.1186/s13014-019-1358-1] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
41 Hashiguchi Y, Muro K, Saito Y, Ito Y, Ajioka Y, Hamaguchi T, Hasegawa K, Hotta K, Ishida H, Ishiguro M, Ishihara S, Kanemitsu Y, Kinugasa Y, Murofushi K, Nakajima TE, Oka S, Tanaka T, Taniguchi H, Tsuji A, Uehara K, Ueno H, Yamanaka T, Yamazaki K, Yoshida M, Yoshino T, Itabashi M, Sakamaki K, Sano K, Shimada Y, Tanaka S, Uetake H, Yamaguchi S, Yamaguchi N, Kobayashi H, Matsuda K, Kotake K, Sugihara K;  Japanese Society for Cancer of the Colon and Rectum. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2019 for the treatment of colorectal cancer. Int J Clin Oncol. 2020;25:1-42. [PMID: 31203527 DOI: 10.1007/s10147-019-01485-z] [Cited by in Crossref: 282] [Cited by in F6Publishing: 260] [Article Influence: 141.0] [Reference Citation Analysis]
42 Lim YJ, Kim Y, Kong M. Comparative survival analysis of preoperative and postoperative radiotherapy in stage II-III rectal cancer on the basis of long-term population data. Sci Rep 2018;8:17153. [PMID: 30464308 DOI: 10.1038/s41598-018-35493-2] [Reference Citation Analysis]
43 Nakamura Y, Matsuda K, Yokoyama S, Tamura K, Mitani Y, Iwamoto H, Mizumoto Y, Murakami D, Fujimoto M, Yamaue H. Alpha-fetoprotein-producing rectal cancer successfully responded to preoperative chemoradiotherapy: case report. Surg Case Rep 2018;4:111. [PMID: 30191347 DOI: 10.1186/s40792-018-0520-6] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
44 Kim JB, Lee JL, Park SH, Kim J, Kim JC. Acute Ileal Perforation Caused by Radiation Enteritis After Restoration. Ann Coloproctol 2021;37:S51-4. [PMID: 32972095 DOI: 10.3393/ac.2020.07.30] [Reference Citation Analysis]
45 Corrò C, Dutoit V, Koessler T. Emerging Trends for Radio-Immunotherapy in Rectal Cancer. Cancers (Basel) 2021;13:1374. [PMID: 33803620 DOI: 10.3390/cancers13061374] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
46 Pai VD, Jatal S, Ostwal V, Engineer R, Arya S, Patil P, Bal M, Saklani AP. Multivisceral resections for rectal cancers: short-term oncological and clinical outcomes from a tertiary-care center in India. J Gastrointest Oncol 2016;7:345-53. [PMID: 27284465 DOI: 10.21037/jgo.2016.01.02] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
47 Li X, Lu H, Xu K, Wang H, Liang X, Hu Z. Negative lymph node count is an independent prognostic factor for patients with rectal cancer who received preoperative radiotherapy. BMC Cancer 2017;17:227. [PMID: 28351352 DOI: 10.1186/s12885-017-3222-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 3.3] [Reference Citation Analysis]
48 Hida J, Okuno K, Tokoro T. Distal dissection in total mesorectal excision, and preoperative chemoradiotherapy and lateral lymph node dissection for rectal cancer. Surg Today 2014;44:2227-42. [PMID: 24363114 DOI: 10.1007/s00595-013-0811-2] [Cited by in Crossref: 14] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
49 Oi H, Okuyama T, Miyazaki S, Ono Y, Oya M. CD133 Expression Predicts Relapse in Patients With Locally Advanced Rectal Cancer Treated With Neoadjuvant Chemotherapy. In Vivo 2021;35:437-45. [PMID: 33402494 DOI: 10.21873/invivo.12276] [Reference Citation Analysis]
50 Schiffmann L, Klautke G, Wedermann N, Gock M, Prall F, Fietkau R, Rau B, Klar E. Prognosis of rectal cancer patients improves with downstaging by intensified neoadjuvant radiochemotherapy - a matched pair analysis. BMC Cancer. 2013;13:388. [PMID: 23947828 DOI: 10.1186/1471-2407-13-388] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
51 Hav M, Libbrecht L, Geboes K, Ferdinande L, Boterberg T, Ceelen W, Pattyn P, Cuvelier C. Prognostic value of tumor shrinkage versus fragmentation following radiochemotherapy and surgery for rectal cancer. Virchows Arch. 2015;466:517-523. [PMID: 25693669 DOI: 10.1007/s00428-015-1723-x] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.3] [Reference Citation Analysis]
52 Qin Q, Wang L. Neoadjuvant therapy and subsequent treatment in rectal cancer: balance between oncological and functional outcomes. J Anus Rectum Colon 2018;2:47-58. [PMID: 31583321 DOI: 10.23922/jarc.2017-049] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
53 Orsini RG, Wiggers T, DeRuiter MC, Quirke P, Beets-Tan RG, van de Velde CJ, Rutten HJ. The modern anatomical surgical approach to localised rectal cancer. EJC Suppl 2013;11:60-71. [PMID: 26217114 DOI: 10.1016/j.ejcsup.2013.07.033] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
54 Wang YW, Huang LY, Song CL, Zhuo CH, Shi DB, Cai GX, Xu Y, Cai SJ, Li XX. Laparoscopic vs open abdominoperineal resection in the multimodality management of low rectal cancers. World J Gastroenterol 2015; 21(35): 10174-10183 [PMID: 26401082 DOI: 10.3748/wjg.v21.i35.10174] [Cited by in CrossRef: 14] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
55 Kontovounisios C, Tekkis P. Locally Advanced Disease and Pelvic Exenterations. Clin Colon Rectal Surg 2017;30:404-14. [PMID: 29200980 DOI: 10.1055/s-0037-1606118] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
56 Wang F, Fan W, Peng J, Lu Z, Pan Z, Li L, Gao Y, Li H, Chen G, Wu X, Ding P, Zeng Z, Wan D. Total mesorectal excision with or without preoperative chemoradiotherapy for resectable mid/low rectal cancer: a long-term analysis of a prospective, single-center, randomized trial. Cancer Commun (Lond) 2018;38:73. [PMID: 30572939 DOI: 10.1186/s40880-018-0342-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.3] [Reference Citation Analysis]
57 Mizushima T, Ikeda M, Kato T, Ikeda A, Nishimura J, Hata T, Matsuda C, Satoh T, Mori M, Doki Y. Postoperative XELOX therapy for patients with curatively resected high-risk stage II and stage III rectal cancer without preoperative chemoradiation: a prospective, multicenter, open-label, single-arm phase II study. BMC Cancer 2019;19:929. [PMID: 31533662 DOI: 10.1186/s12885-019-6122-2] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
58 Cui Y, Yang X, Shi Z, Yang Z, Du X, Zhao Z, Cheng X. Radiomics analysis of multiparametric MRI for prediction of pathological complete response to neoadjuvant chemoradiotherapy in locally advanced rectal cancer. Eur Radiol. 2019;29:1211-1220. [PMID: 30128616 DOI: 10.1007/s00330-018-5683-9] [Cited by in Crossref: 75] [Cited by in F6Publishing: 70] [Article Influence: 25.0] [Reference Citation Analysis]
59 Grosek J, Novak J, Kitek K, Bajric A, Majdic A, Kosir JA, Tomazic A. Health-related quality of life in Slovenian patients with colorectal cancer: a single tertiary care center study. Radiol Oncol 2019;53:231-7. [PMID: 30893057 DOI: 10.2478/raon-2019-0015] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
60 Deo SV, Kapali AS, Gupta M, Shukla NK. A review of controversies in the management of colorectal cancers. Indian J Surg 2012;74:221-7. [PMID: 23730048 DOI: 10.1007/s12262-012-0586-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.4] [Reference Citation Analysis]
61 Jin P, Jiang J, Xie N, Zhou L, Huang Z, Zhang L, Qin S, Fu S, Peng L, Gao W, Li B, Lei Y, Nice EC, Li C, Shao J, Xie K. MCT1 relieves osimertinib-induced CRC suppression by promoting autophagy through the LKB1/AMPK signaling. Cell Death Dis 2019;10:615. [PMID: 31409796 DOI: 10.1038/s41419-019-1844-2] [Cited by in Crossref: 13] [Cited by in F6Publishing: 16] [Article Influence: 6.5] [Reference Citation Analysis]
62 Krishnamurty DM, Hawkins AT, Wells KO, Mutch MG, Silviera ML, Glasgow SC, Hunt SR, Dharmarajan S. Neoadjuvant Radiation Therapy in Locally Advanced Colon Cancer: a Cohort Analysis. J Gastrointest Surg 2018;22:906-12. [PMID: 29427227 DOI: 10.1007/s11605-018-3676-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
63 Wyld L, Audisio RA, Poston GJ. The evolution of cancer surgery and future perspectives. Nat Rev Clin Oncol 2015;12:115-24. [PMID: 25384943 DOI: 10.1038/nrclinonc.2014.191] [Cited by in Crossref: 84] [Cited by in F6Publishing: 73] [Article Influence: 12.0] [Reference Citation Analysis]
64 Contin P, Kulu Y, Bruckner T, Sturm M, Welsch T, Müller-stich BP, Huber J, Büchler MW, Ulrich A. Comparative analysis of late functional outcome following preoperative radiation therapy or chemoradiotherapy and surgery or surgery alone in rectal cancer. Int J Colorectal Dis 2014;29:165-75. [DOI: 10.1007/s00384-013-1780-z] [Cited by in Crossref: 56] [Cited by in F6Publishing: 41] [Article Influence: 7.0] [Reference Citation Analysis]
65 Quezada-Diaz F, Jimenez-Rodriguez RM, Pappou EP, Joshua Smith J, Patil S, Wei I, Guillem JG, Paty PB, Nash GM, Weiser MR, Garcia-Aguilar J. Effect of Neoadjuvant Systemic Chemotherapy With or Without Chemoradiation on Bowel Function in Rectal Cancer Patients Treated With Total Mesorectal Excision.J Gastrointest Surg. 2019;23:800-807. [PMID: 30350191 DOI: 10.1007/s11605-018-4003-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
66 Lakkis Z, Panis Y. Is There Any Reason Not to Perform Standard Laparoscopic Total Mesorectal Excision? Clin Colon Rectal Surg 2017;30:333-8. [PMID: 29184468 DOI: 10.1055/s-0037-1606110] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
67 Faruk M, Ibrahim S, Aminu SM, Adamu A, Abdullahi A, Suleiman AM, Rafindadi AH, Mohammed A, Iliyasu Y, Idoko J, Saidu R, Randawa AJ, Musa HS, Ntekim A, Shah KZ, Abubakar S, Adoke KU, Manko M, Awasum CA. Prognostic significance of BIRC7/Livin, Bcl-2, p53, Annexin V, PD-L1, DARC, MSH2 and PMS2 in colorectal cancer treated with FOLFOX chemotherapy with or without aspirin. PLoS One 2021;16:e0245581. [PMID: 33465114 DOI: 10.1371/journal.pone.0245581] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
68 Li Q, Peng Y, Wang LA, Wei X, Li MX, Qing Y, Xia W, Cheng M, Zi D, Li CX, Wang D. The influence of neoadjuvant therapy for the prognosis in patients with rectal carcinoma: a retrospective study. Tumour Biol 2016;37:3441-9. [PMID: 26449827 DOI: 10.1007/s13277-015-4153-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
69 Abu-Zaied MA, Loutfy SA, Hassan AE, Elgemeie GH. Novel purine thioglycoside analogs: synthesis, nanoformulation and biological evaluation in in vitro human liver and breast cancer models. Drug Des Devel Ther 2019;13:2437-57. [PMID: 31440030 DOI: 10.2147/DDDT.S201249] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
70 Pach R, Richter P, Sierzega M, Papp N, Szczepanik A. Preoperative Short-Course Radiotherapy and Surgery versus Surgery Alone for Patients with Rectal Cancer: A Propensity Score-Matched Analysis at 18-Year Follow-Up. Biomedicines 2021;9:725. [PMID: 34202691 DOI: 10.3390/biomedicines9070725] [Reference Citation Analysis]
71 Peng JY, Li ZN, Wang Y. Risk factors for local recurrence following neoadjuvant chemoradiotherapy for rectal cancers. World J Gastroenterol 2013; 19(32): 5227-5237 [PMID: 23983425 DOI: 10.3748/wjg.v19.i32.5227] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 1.3] [Reference Citation Analysis]
72 Ji D, Song C, Li Y, Xia J, Wu Y, Jia J, Cui X, Yu S, Gu J. Combination of radiotherapy and suppression of Tregs enhances abscopal antitumor effect and inhibits metastasis in rectal cancer. J Immunother Cancer 2020;8:e000826. [PMID: 33106387 DOI: 10.1136/jitc-2020-000826] [Cited by in Crossref: 14] [Cited by in F6Publishing: 14] [Article Influence: 14.0] [Reference Citation Analysis]
73 Zwahlen DR, Bischoff LI, Gruber G, Sumila M, Schneider U. Estimation of second cancer risk after radiotherapy for rectal cancer: comparison of 3D conformal radiotherapy and volumetric modulated arc therapy using different high dose fractionation schemes. Radiat Oncol 2016;11:149. [PMID: 27832799 DOI: 10.1186/s13014-016-0723-6] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 1.4] [Reference Citation Analysis]
74 Avila S, Chang GJ, Dasari NA, Smani DA, Das P, Herman JM, Koay E, Koong A, Krishnan S, Minsky BD, Smith GL, Taniguchi C, Taggart MW, Kaur H, Holliday EB. Pathologic Response and Postoperative Complications After Short-course Radiation Therapy and Chemotherapy for Patients With Rectal Adenocarcinoma. Clin Colorectal Cancer 2020;19:116-22. [PMID: 32173279 DOI: 10.1016/j.clcc.2020.02.005] [Reference Citation Analysis]
75 Yoo BC, Yeo SG. Clinical utility of pretreatment prediction of chemoradiotherapy response in rectal cancer: a review. EPMA J 2017;8:61-7. [PMID: 28620444 DOI: 10.1007/s13167-017-0082-x] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.3] [Reference Citation Analysis]
76 Kamran SC, Lennerz JK, Margolis CA, Liu D, Reardon B, Wankowicz SA, Van Seventer EE, Tracy A, Wo JY, Carter SL, Willers H, Corcoran RB, Hong TS, Van Allen EM. Integrative Molecular Characterization of Resistance to Neoadjuvant Chemoradiation in Rectal Cancer. Clin Cancer Res. 2019;25:5561-5571. [PMID: 31253631 DOI: 10.1158/1078-0432.ccr-19-0908] [Cited by in Crossref: 25] [Cited by in F6Publishing: 15] [Article Influence: 12.5] [Reference Citation Analysis]
77 Velthuis S, Nieuwenhuis DH, Ruijter TE, Cuesta MA, Bonjer HJ, Sietses C. Transanal versus traditional laparoscopic total mesorectal excision for rectal carcinoma. Surg Endosc. 2014;28:3494-3499. [PMID: 24972923 DOI: 10.1007/s00464-014-3636-1] [Cited by in Crossref: 136] [Cited by in F6Publishing: 108] [Article Influence: 19.4] [Reference Citation Analysis]
78 Meng X, Huang Z, Wang R, Jiao Y, Li H, Xu X, Feng R, Zhu K, Jiang S, Yan H, Yu J. The prognostic role of EZH2 expression in rectal cancer patients treated with neoadjuvant chemoradiotherapy. Radiat Oncol 2014;9:188. [PMID: 25159232 DOI: 10.1186/1748-717X-9-188] [Cited by in Crossref: 10] [Cited by in F6Publishing: 5] [Article Influence: 1.4] [Reference Citation Analysis]
79 Plodeck V, Platzek I, Streitzig J, Nebelung H, Blum S, Kühn JP, Hoffmann RT, Laniado M, Michler E, Hoberück S, Zöphel K, Kotzerke J, Fritzmann J, Weitz J, Radosa CG. Diagnostic performance of 18F-fluorodeoxyglucose-PET/MRI versus MRI alone in the diagnosis of pelvic recurrence of rectal cancer. Abdom Radiol (NY) 2021. [PMID: 34402948 DOI: 10.1007/s00261-021-03224-3] [Reference Citation Analysis]
80 Nilsson PJ, van Etten B, Hospers GA, Påhlman L, van de Velde CJ, Beets-Tan RG, Blomqvist L, Beukema JC, Kapiteijn E, Marijnen CA, Nagtegaal ID, Wiggers T, Glimelius B. Short-course radiotherapy followed by neo-adjuvant chemotherapy in locally advanced rectal cancer--the RAPIDO trial. BMC Cancer 2013;13:279. [PMID: 23742033 DOI: 10.1186/1471-2407-13-279] [Cited by in Crossref: 198] [Cited by in F6Publishing: 160] [Article Influence: 24.8] [Reference Citation Analysis]
81 Guan X, Jia S, Chen W, Jiang Z, Liu Z, Chen Y, Wang G, Wang X. Long-term Effect of Radiotherapy in Rectal Cancer Patients with Mucinous Tumor: A Large Population Based Study. Sci Rep 2017;7:43821. [PMID: 28272410 DOI: 10.1038/srep43821] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
82 Sarioglu S, Ikiz AO. Radial/Circumferential Surgical Margin in Laryngectomy Specimens. Head Neck Pathol 2017;11:413-5. [PMID: 28289982 DOI: 10.1007/s12105-017-0805-2] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
83 Zhang A, Liu T, Zheng K, Liu N, Huang F, Li W, Liu T, Fu W. Estimation of physiologic ability and surgical stress (E-PASS) scoring system could provide preoperative advice on whether to undergo laparoscopic surgery for colorectal cancer patients with a high physiological risk. Medicine (Baltimore) 2017;96:e7772. [PMID: 28816959 DOI: 10.1097/MD.0000000000007772] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
84 Okuyama T, Sameshima S, Takeshita E, Yoshioka R, Yamagata Y, Ono Y, Tagaya N, Noie T, Oya M. Therapeutic effects of oxaliplatin-based neoadjuvant chemotherapy and chemoradiotherapy in patients with locally advanced rectal cancer: a single-center, retrospective cohort study.World J Surg Oncol. 2018;16:105. [PMID: 29871650 DOI: 10.1186/s12957-018-1403-9] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
85 Ogura A, Akiyoshi T, Nagasaki T, Konishi T, Fujimoto Y, Nagayama S, Fukunaga Y, Ueno M, Kuroyanagi H. Feasibility of Laparoscopic Total Mesorectal Excision with Extended Lateral Pelvic Lymph Node Dissection for Advanced Lower Rectal Cancer after Preoperative Chemoradiotherapy. World J Surg. 2017;41:868-875. [PMID: 27730352 DOI: 10.1007/s00268-016-3762-0] [Cited by in Crossref: 38] [Cited by in F6Publishing: 34] [Article Influence: 9.5] [Reference Citation Analysis]
86 Lu HC, Wang F, Yin JD. Texture Analysis Based on Sagittal Fat-Suppression and Transverse T2-Weighted Magnetic Resonance Imaging for Determining Local Invasion of Rectal Cancer.Front Oncol. 2020;10:1476. [PMID: 33014786 DOI: 10.3389/fonc.2020.01476] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
87 Kim MJ, Cho JS, Kim EM, Ko WA, Oh JH. Optimal Time Interval for Surgery After Neoadjuvant Chemoradiotherapy in Patients With Locally Advanced Rectal Cancer: Analysis of Health Insurance Review and Assessment Service Data. Ann Coloproctol. 2018;34:241-247. [PMID: 30419721 DOI: 10.3393/ac.2018.01.01] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
88 Lin C, Ng HL, Pan W, Chen H, Zhang G, Bian Z, Lu A, Yang Z. Exploring Different Strategies for Efficient Delivery of Colorectal Cancer Therapy. Int J Mol Sci 2015;16:26936-52. [PMID: 26569228 DOI: 10.3390/ijms161125995] [Cited by in Crossref: 21] [Cited by in F6Publishing: 18] [Article Influence: 3.5] [Reference Citation Analysis]
89 Sterzing F, Hoehle F, Ulrich A, Jensen A, Debus J, Muenter M. Clinical results and toxicity for short-course preoperative radiotherapy and total mesorectal excision in rectal cancer patients. J Radiat Res 2015;56:169-76. [PMID: 25341424 DOI: 10.1093/jrr/rru089] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 1.1] [Reference Citation Analysis]
90 Ye DX, Wang SS, Huang Y, Wang XJ, Chi P. USP43 directly regulates ZEB1 protein, mediating proliferation and metastasis of colorectal cancer. J Cancer 2021;12:404-16. [PMID: 33391437 DOI: 10.7150/jca.48056] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
91 Gillespie MA, Steele CW, Lannagan TRM, Sansom OJ, Roxburgh CSD. Pre-clinical modelling of rectal cancer to develop novel radiotherapy-based treatment strategies. Oncol Rev 2021;15:511. [PMID: 34249240 DOI: 10.4081/oncol.2021.511] [Reference Citation Analysis]
92 Liu X, Zheng S, Peng Y, Zhuang J, Yang Y, Xu Y, Guan G. Construction of the Prediction Model for Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy Based on Pretreatment Tumor-Infiltrating Macrophage-Associated Biomarkers. Onco Targets Ther 2021;14:2599-610. [PMID: 33880038 DOI: 10.2147/OTT.S297263] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
93 Wegner RE, White RJ, Hasan S, Raj M, Monga D, Finley G, Kirichenko AV, Mccormick J. Anal adenocarcinoma: Treatment outcomes and trends in a rare disease entity. Cancer Med 2019;8:3855-63. [DOI: 10.1002/cam4.2076] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 2.5] [Reference Citation Analysis]
94 Park M, Kwon J, Kong J, Moon SM, Cho S, Yang KY, Jang WI, Kim MS, Kim Y, Shin US. A Patient-Derived Organoid-Based Radiosensitivity Model for the Prediction of Radiation Responses in Patients with Rectal Cancer. Cancers (Basel) 2021;13:3760. [PMID: 34359661 DOI: 10.3390/cancers13153760] [Reference Citation Analysis]
95 Marijnen CAM, Peters FP, Rödel C, Bujko K, Haustermans K, Fokas E, Glynne-Jones R, Valentini V, Spindler KG, Guren MG, Maingon P, Calvo FA, Pares O, Glimelius B, Sebag-Montefiore D. International expert consensus statement regarding radiotherapy treatment options for rectal cancer during the COVID 19 pandemic. Radiother Oncol 2020;148:213-5. [PMID: 32342861 DOI: 10.1016/j.radonc.2020.03.039] [Cited by in Crossref: 36] [Cited by in F6Publishing: 32] [Article Influence: 36.0] [Reference Citation Analysis]
96 Ceelen WP. Progress in rectal cancer treatment. ISRN Gastroenterol 2012;2012:648183. [PMID: 22970381 DOI: 10.5402/2012/648183] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 0.6] [Reference Citation Analysis]
97 Li J, Liu Y, Wang JW, Gao Y, Hu YT, He JJ, Yu XY, Hu HG, Yuan Y, Zhang SZ, Ding KF. Oxaliplatin-based adjuvant chemotherapy without radiotherapy can improve the survival of locally-advanced rectal cancer. PLoS One 2014;9:e107872. [PMID: 25243406 DOI: 10.1371/journal.pone.0107872] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
98 Chadi SA, Berho M, Wexner SD. Surgeon perspectives on the use and effects of neoadjuvant chemoradiation in the treatment of rectal cancer: a comprehensive review of the literature. Langenbecks Arch Surg 2015;400:661-73. [PMID: 26250144 DOI: 10.1007/s00423-015-1328-5] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
99 Yamashita K, Matsuda T, Hasegawa H, Mukohyama J, Arimoto A, Tanaka T, Yamamoto M, Matsuda Y, Kanaji S, Nakamura T, Sumi Y, Suzuki S, Kakeji Y. Recent advances of neoadjuvant chemoradiotherapy in rectal cancer: Future treatment perspectives. Ann Gastroenterol Surg 2019;3:24-33. [PMID: 30697607 DOI: 10.1002/ags3.12213] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
100 De Palma FDE, Luglio G, Tropeano FP, Pagano G, D'Armiento M, Kroemer G, Maiuri MC, De Palma GD. The Role of Micro-RNAs and Circulating Tumor Markers as Predictors of Response to Neoadjuvant Therapy in Locally Advanced Rectal Cancer. Int J Mol Sci 2020;21:E7040. [PMID: 32987896 DOI: 10.3390/ijms21197040] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
101 de'Angelis N, Pigneur F, Martínez-Pérez A, Vitali GC, Landi F, Torres-Sánchez T, Rodrigues V, Memeo R, Bianchi G, Brunetti F, Espin E, Ris F, Luciani A; EuMaRCS Study Group. Predictors of surgical outcomes and survival in rectal cancer patients undergoing laparoscopic total mesorectal excision after neoadjuvant chemoradiation therapy: the interest of pelvimetry and restaging magnetic resonance imaging studies. Oncotarget 2018;9:25315-31. [PMID: 29861874 DOI: 10.18632/oncotarget.25431] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
102 Zhang X, Gao Y, Dai X, Zhang H, Shang Z, Cai X, Shen T, Cheng X, Yu K, Li Y. Short- and long-term outcomes of transanal versus laparoscopic total mesorectal excision for mid-to-low rectal cancer: a meta-analysis. Surg Endosc 2019;33:972-85. [PMID: 30374790 DOI: 10.1007/s00464-018-6527-z] [Cited by in Crossref: 19] [Cited by in F6Publishing: 14] [Article Influence: 6.3] [Reference Citation Analysis]
103 Pai VD, Engineer R, Patil PS, Arya S, Desouza AL, Saklani AP. Selective extra levator versus conventional abdomino perineal resection: experience from a tertiary-care center. J Gastrointest Oncol 2016;7:354-9. [PMID: 27284466 DOI: 10.21037/jgo.2015.11.05] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
104 Liu Z, Wang S, Dong D, Wei J, Fang C, Zhou X, Sun K, Li L, Li B, Wang M, Tian J. The Applications of Radiomics in Precision Diagnosis and Treatment of Oncology: Opportunities and Challenges. Theranostics. 2019;9:1303-1322. [PMID: 30867832 DOI: 10.7150/thno.30309] [Cited by in Crossref: 149] [Cited by in F6Publishing: 140] [Article Influence: 74.5] [Reference Citation Analysis]
105 Kim Y, Kim DY, Kim TH, Kim SY, Baek JY, Kim MJ, Chang HJ, Cha Y, Park SC, Oh JH. Patterns of failure in rectal cancer with positive circumferential resection margin after surgery following preoperative chemoradiation: a propensity score matching analysis. Br J Radiol 2018;91:20180143. [PMID: 30129789 DOI: 10.1259/bjr.20180143] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
106 Chand M, Swift RI, Chau I, Heald RJ, Tekkis PP, Brown G. Adjuvant therapy decisions based on magnetic resonance imaging of extramural venous invasion and other prognostic factors in colorectal cancer. Ann R Coll Surg Engl. 2014;96:543-546. [PMID: 25245736 DOI: 10.1308/003588414x13814021678835] [Cited by in Crossref: 15] [Cited by in F6Publishing: 8] [Article Influence: 2.1] [Reference Citation Analysis]
107 Kaiser AM. Evolution and future of laparoscopic colorectal surgery. World J Gastroenterol 2014; 20(41): 15119-15124 [PMID: 25386060 DOI: 10.3748/wjg.v20.i41.15119] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
108 Rubio J, Cristóbal I, Santos A, Caramés C, Luque M, Sanz-Alvarez M, Zazo S, Madoz-Gúrpide J, Rojo F, García-Foncillas J. Low MicroRNA-19b Expression Shows a Promising Clinical Impact in Locally Advanced Rectal Cancer. Cancers (Basel) 2021;13:1456. [PMID: 33810186 DOI: 10.3390/cancers13061456] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
109 Wang Y, He XH, Xu LC, Huang HZ, Li GD, Wang YH, Li WT, Wang GZ. CT-guided cryoablation for unresectable pelvic recurrent colorectal cancer: a retrospective study. Onco Targets Ther 2019;12:1379-87. [PMID: 30863104 DOI: 10.2147/OTT.S189897] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
110 Zhu HT, Zhang XY, Shi YJ, Li XT, Sun YS. A Deep Learning Model to Predict the Response to Neoadjuvant Chemoradiotherapy by the Pretreatment Apparent Diffusion Coefficient Images of Locally Advanced Rectal Cancer. Front Oncol. 2020;10:574337. [PMID: 33194680 DOI: 10.3389/fonc.2020.574337] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
111 van Eeghen EE, Bakker SD, Fransen G, Flens MJ, Loffeld RJLF. Tumor stage in patients operated for rectal cancer: a comparison of the pre-operative MR and the resection specimen, with specific attention to the effect of neo-adjuvant radiotherapy. J Gastrointest Oncol 2017;8:625-8. [PMID: 28890811 DOI: 10.21037/jgo.2017.04.05] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
112 Hanna CR, Slevin F, Appelt A, Beavon M, Adams R, Arthur C, Beasley M, Duffton A, Gilbert A, Gollins S, Harrison M, Hawkins MA, Laws K, O'Cathail S, Porcu P, Robinson M, Sebag-Montefiore D, Teo M, Teoh S, Muirhead R. Intensity-modulated Radiotherapy for Rectal Cancer in the UK in 2020. Clin Oncol (R Coll Radiol) 2021;33:214-23. [PMID: 33423883 DOI: 10.1016/j.clon.2020.12.011] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
113 Sclafani F, Brown G, Cunningham D, Rao S, Tekkis P, Tait D, Morano F, Baratelli C, Kalaitzaki E, Rasheed S, Watkins D, Starling N, Wotherspoon A, Chau I. Systemic Chemotherapy as Salvage Treatment for Locally Advanced Rectal Cancer Patients Who Fail to Respond to Standard Neoadjuvant Chemoradiotherapy. Oncologist 2017;22:728-36. [PMID: 28476941 DOI: 10.1634/theoncologist.2016-0396] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.8] [Reference Citation Analysis]
114 Park SH, Kim JC. Preoperative chemoradiation for locally advanced rectal cancer: comparison of three radiation dose and fractionation schedules. Radiat Oncol J 2016;34:96-105. [PMID: 27306773 DOI: 10.3857/roj.2016.01704] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
115 Asoglu O, Balik E, Kunduz E, Yamaner S, Akyuz A, Gulluoglu M, Kapran Y, Bugra D. Laparoscopic surgery for rectal cancer: outcomes in 513 patients. World J Surg 2013;37:883-92. [PMID: 23361097 DOI: 10.1007/s00268-013-1927-7] [Cited by in Crossref: 13] [Cited by in F6Publishing: 14] [Article Influence: 1.6] [Reference Citation Analysis]
116 Wang H, Wang L, Jiang Y, Ji Z, Guo F, Jiang P, Li X, Chen Y, Sun H, Fan J, Du G, Wang J. Long-Term Outcomes and Prognostic Analysis of Computed Tomography-Guided Radioactive 125I Seed Implantation for Locally Recurrent Rectal Cancer After External Beam Radiotherapy or Surgery. Front Oncol 2020;10:540096. [PMID: 33552943 DOI: 10.3389/fonc.2020.540096] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
117 VanderWalde NA, Williams GR. Developing an electronic geriatric assessment to improve care of older adults with cancer receiving radiotherapy. Tech Innov Patient Support Radiat Oncol 2020;16:24-9. [PMID: 33385071 DOI: 10.1016/j.tipsro.2020.09.002] [Reference Citation Analysis]
118 Ye SB, Cheng YK, Zhang L, Zou YF, Chen P, Deng YH, Huang Y, Peng JH, Wu XJ, Lan P. Association of mismatch repair status with survival and response to neoadjuvant chemo(radio)therapy in rectal cancer. NPJ Precis Oncol 2020;4:26. [PMID: 32964128 DOI: 10.1038/s41698-020-00132-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
119 Wolf M, Zehentmayr F, Belka C. [Radiotherapy of rectal cancer]. Radiologe 2012;52:545-9. [PMID: 22618627 DOI: 10.1007/s00117-011-2286-8] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
120 Zhao F, Wang J, Yu H, Cheng X, Li X, Zhu X, Xu X, Lin J, Chen X, Yan S. Neoadjuvant radiotherapy improves overall survival for T3/4N+M0 rectal cancer patients: a population-based study of 20300 patients. Radiat Oncol 2020;15:49. [PMID: 32103755 DOI: 10.1186/s13014-020-01497-4] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
121 Glimelius B. Neo-adjuvant radiotherapy in rectal cancer. World J Gastroenterol 2013; 19(46): 8489-8501 [PMID: 24379566 DOI: 10.3748/wjg.v19.i46.8489] [Cited by in CrossRef: 40] [Cited by in F6Publishing: 38] [Article Influence: 5.0] [Reference Citation Analysis]
122 Koizumi M, Yamada T, Shinji S, Yokoyama Y, Takahashi G, Iwai T, Takeda K, Hara K, Ohta K, Uchida E, Yoshida H. Feasibility of Neoadjuvant FOLFOX Therapy Without Radiotherapy for Baseline Resectable Rectal Cancer. In Vivo. 2018;32:937-943. [PMID: 29936483 DOI: 10.21873/invivo.11332] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 3.3] [Reference Citation Analysis]
123 Buchs NC, Penna M, Bloemendaal AL, Hompes R. Transanal total mesorectal excision: Myths and reality. World J Clin Oncol 2016; 7(5): 337-339 [PMID: 27777876 DOI: 10.5306/wjco.v7.i5.337] [Cited by in CrossRef: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.2] [Reference Citation Analysis]
124 Buchs NC, Nicholson GA, Ris F, Mortensen NJ, Hompes R. Transanal total mesorectal excision: A valid option for rectal cancer? World J Gastroenterol 2015; 21(41): 11700-11708 [PMID: 26556997 DOI: 10.3748/wjg.v21.i41.11700] [Cited by in CrossRef: 27] [Cited by in F6Publishing: 23] [Article Influence: 4.5] [Reference Citation Analysis]
125 Liao YT, Lin YL, Huang J, Hung JS, Lin BR. Downstaged ypT0-2N0 rectal cancer after neoadjuvant chemoradiation therapy may not need adjuvant chemotherapy: a retrospective cohort study. Int J Colorectal Dis 2021;36:509-16. [PMID: 33128083 DOI: 10.1007/s00384-020-03787-5] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
126 Huang XZ, Gao P, Song YX, Sun JX, Chen XW, Zhao JH, Ma B, Wang J, Wang ZN. Impact of age on efficacy of postoperative oxaliplatin-based chemotherapy in patients with rectal cancer after neoadjuvant chemoradiotherapy. Oncotarget 2016;7:19643-53. [PMID: 26910371 DOI: 10.18632/oncotarget.7544] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 2.3] [Reference Citation Analysis]
127 Kim JH. Controversial issues in radiotherapy for rectal cancer: a systematic review. Radiat Oncol J 2017;35:295-305. [PMID: 29325395 DOI: 10.3857/roj.2017.00395] [Cited by in Crossref: 12] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
128 Santos MD, Silva C, Rocha A, Matos E, Nogueira C, Lopes C. Prognostic value of mandard and dworak tumor regression grading in rectal cancer: study of a single tertiary center. ISRN Surg. 2014;2014:310542. [PMID: 24729903 DOI: 10.1155/2014/310542] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 1.7] [Reference Citation Analysis]
129 Bosch SL, Verhoeven RHA, Lemmens VEPP, Simmer F, Poortmans P, de Wilt JHW, Nagtegaal ID. Type of preoperative therapy and stage-specific survival after surgery for rectal cancer: a nationwide population-based cohort study. Virchows Arch 2019;475:745-55. [PMID: 31463728 DOI: 10.1007/s00428-019-02638-1] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
130 Seo I, Lee HW, Byun SJ, Park JY, Min H, Lee SH, Lee JS, Kim S, Bae SU. Neoadjuvant chemoradiation alters biomarkers of anticancer immunotherapy responses in locally advanced rectal cancer. J Immunother Cancer 2021;9:e001610. [PMID: 33692216 DOI: 10.1136/jitc-2020-001610] [Reference Citation Analysis]
131 Chung MJ, Kim DW, Chung WK, Lee SH, Jeong SK, Hwang JK, Jeong CS. Preoperative short- vs. long-course chemoradiotherapy with delayed surgery for locally advanced rectal cancer. Oncotarget 2017;8:60479-86. [PMID: 28947986 DOI: 10.18632/oncotarget.10280] [Cited by in Crossref: 10] [Cited by in F6Publishing: 9] [Article Influence: 2.0] [Reference Citation Analysis]
132 Kulu Y, Büchler MW, Ulrich A. [Radiotherapy-associated morbidity and mortality in rectal surgery]. Chirurg 2013;84:951-6. [PMID: 24170116 DOI: 10.1007/s00104-013-2515-y] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
133 Otero de Pablos J, Mayol J. Controversies in the Management of Lateral Pelvic Lymph Nodes in Patients With Advanced Rectal Cancer: East or West? Front Surg 2019;6:79. [PMID: 32010707 DOI: 10.3389/fsurg.2019.00079] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 5.0] [Reference Citation Analysis]
134 Olsson LI, Granstrom F. Socioeconomic inequalities in relative survival of rectal cancer most obvious in stage III. World J Surg 2014;38:3265-75. [PMID: 25189440 DOI: 10.1007/s00268-014-2735-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.5] [Reference Citation Analysis]
135 Zhao N, Lin CJ, Wang F, Lin C. Short-course or long-course radiation therapy as a part of a neoadjuvant regimen for stage II & III rectal adenocarcinoma? Chin J Cancer Res 2019;31:849-52. [PMID: 31949387 DOI: 10.21147/j.issn.1000-9604.2019.06.01] [Reference Citation Analysis]
136 Zhang LN, Xiao WW, Xi SY, OuYang PY, You KY, Zeng ZF, Ding PR, Zhang HZ, Pan ZZ, Xu RH, Gao YH. Tumor deposits: markers of poor prognosis in patients with locally advanced rectal cancer following neoadjuvant chemoradiotherapy. Oncotarget 2016;7:6335-44. [PMID: 26695441 DOI: 10.18632/oncotarget.6656] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
137 Liu Q, Shan Z, Luo D, Cai S, Li Q, Li X. Palliative beam radiotherapy offered real-world survival benefit to metastatic rectal cancer: A large US population-based and propensity score-matched study. J Cancer 2019;10:1216-25. [PMID: 30854131 DOI: 10.7150/jca.28768] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
138 Cristóbal I, Santos A, Rubio J, Caramés C, Zazo S, Sanz-Álvarez M, Luque M, Madoz-Gúrpide J, Rojo F, García-Foncillas J. Validation of microRNA-199b as A Promising Predictor of Outcome and Response to Neoadjuvant Treatment in Locally Advanced Rectal Cancer Patients. Cancers (Basel) 2021;13:5003. [PMID: 34638487 DOI: 10.3390/cancers13195003] [Reference Citation Analysis]
139 Zhang Y, Xu M, Chen J, Chen K, Zhuang J, Yang Y, Liu X, Guan G. Prognostic Value of the FOXK Family Expression in Patients with Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy. Onco Targets Ther 2020;13:9185-201. [PMID: 32982306 DOI: 10.2147/OTT.S255956] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
140 Uehara K, Nagino M. Neoadjuvant treatment for locally advanced rectal cancer: a systematic review. Surg Today 2016;46:161-8. [PMID: 26170102 DOI: 10.1007/s00595-015-1218-z] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 2.7] [Reference Citation Analysis]
141 Ciria JP, Eguiguren M, Cafiero S, Uranga I, Diaz de Cerio I, Querejeta A, Urraca JM, Minguez J, Guimon E, Puertolas JR. Could preoperative short-course radiotherapy be the treatment of choice for localized advanced rectal carcinoma? Rep Pract Oncol Radiother 2015;20:1-11. [PMID: 25535578 DOI: 10.1016/j.rpor.2014.06.003] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 0.7] [Reference Citation Analysis]
142 Jin F, Luo H, Zhou J, Wu Y, Sun H, Liu H, Zheng X, Wang Y. Dose-time fractionation schedules of preoperative radiotherapy and timing to surgery for rectal cancer. Ther Adv Med Oncol 2020;12:1758835920907537. [PMID: 32165928 DOI: 10.1177/1758835920907537] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 4.0] [Reference Citation Analysis]
143 Ahmed S, Eng C. Neoadjuvant Strategies: Locally Advanced Rectal Cancer. Clin Colon Rectal Surg. 2017;30:383-386. [PMID: 29184474 DOI: 10.1055/s-0037-1606372] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.8] [Reference Citation Analysis]
144 Glynne-Jones R, Chau I. Neoadjuvant therapy before surgical treatment. EJC Suppl 2013;11:45-59. [PMID: 26217113 DOI: 10.1016/j.ejcsup.2013.07.032] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
145 Lee JL, Lim SB, Yu CS, Park IJ, Yoon YS, Kim CW, Park SH, Lee JS, Hong YS, Kim SY, Kim JE, Kim JH, Park JH, Kim J, Han M. Local excision in mid-to-low rectal cancer patients who revealed clinically total or near-total regression after preoperative chemoradiotherapy; a proposed trial. BMC Cancer 2019;19:404. [PMID: 31035949 DOI: 10.1186/s12885-019-5581-9] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
146 Qiu B, Ding PR, Cai L, Xiao WW, Zeng ZF, Chen G, Lu ZH, Li LR, Wu XJ, Mirimanoff RO, Pan ZZ, Xu RH, Gao YH. Outcomes of preoperative chemoradiotherapy followed by surgery in patients with unresectable locally advanced sigmoid colon cancer. Chin J Cancer. 2016;35:65. [PMID: 27389519 DOI: 10.1186/s40880-016-0126-y] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
147 Liu H, Wei R, Li C, Zhao Z, Guan X, Yang M, Liu Z, Wang X, Jiang Z. BMI May Be a Prognostic Factor for Local Advanced Rectal Cancer Patients Treated with Long-Term Neoadjuvant Chemoradiotherapy. Cancer Manag Res 2020;12:10321-32. [PMID: 33116887 DOI: 10.2147/CMAR.S268928] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
148 Yu M, Jang HS, Jeon DM, Cheon GS, Lee HC, Chung MJ, Kim SH, Lee JH. Dosimetric evaluation of Tomotherapy and four-box field conformal radiotherapy in locally advanced rectal cancer. Radiat Oncol J 2013;31:252-9. [PMID: 24501715 DOI: 10.3857/roj.2013.31.4.252] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 1.9] [Reference Citation Analysis]
149 Jäger T, Neureiter D, Fallaha M, Schredl P, Kiesslich T, Urbas R, Klieser E, Holzinger J, Sedlmayer F, Emmanuel K, Dinnewitzer A. The potential predictive value of tumor budding for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer. Strahlenther Onkol 2018;194:991-1006. [PMID: 30069738 DOI: 10.1007/s00066-018-1340-0] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
150 Xing XL, Xing C, Huang Z, Yao ZY, Liu YW. Immune-Related lncRNAs to Construct Novel Signatures and Predict the Prognosis of Rectal Cancer. Front Oncol 2021;11:661846. [PMID: 34485113 DOI: 10.3389/fonc.2021.661846] [Reference Citation Analysis]
151 Song JH, Jeong JU, Lee JH, Kim SH, Cho HM, Um JW, Jang HS; Korean Clinical Practice Guideline for Colon and Rectal Cancer Committee. Preoperative chemoradiotherapy versus postoperative chemoradiotherapy for stage II-III resectable rectal cancer: a meta-analysis of randomized controlled trials. Radiat Oncol J 2017;35:198-207. [PMID: 29037017 DOI: 10.3857/roj.2017.00059] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
152 Yukimoto R, Uemura M, Tsuboyama T, Hata T, Fujino S, Ogino T, Miyoshi N, Takahashi H, Hata T, Yamamoto H, Mizushima T, Kida A, Furuyashiki M, Doki Y, Eguchi H. Efficacy of positron emission tomography in diagnosis of lateral lymph node metastases in patients with rectal Cancer: a retrospective study. BMC Cancer 2021;21:520. [PMID: 33962569 DOI: 10.1186/s12885-021-08278-6] [Reference Citation Analysis]
153 Wang TH, Liu CJ, Chao TF, Chen TJ, Hu YW. Second primary malignancy risk after radiotherapy in rectal cancer survivors. World J Gastroenterol 2018; 24(40): 4586-4595 [PMID: 30386108 DOI: 10.3748/wjg.v24.i40.4586] [Cited by in CrossRef: 7] [Cited by in F6Publishing: 7] [Article Influence: 2.3] [Reference Citation Analysis]
154 Kim HS, Kim NK. Challenges and shifting treatment strategies in the surgical treatment of locally advanced rectal cancer. Ann Gastroenterol Surg 2020;4:379-85. [PMID: 32724881 DOI: 10.1002/ags3.12349] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
155 Zhao J, Chen Z, Wang J, Xia F, Peng J, Hu Y, Hu W, Zhang Z. MV CBCT-Based Synthetic CT Generation Using a Deep Learning Method for Rectal Cancer Adaptive Radiotherapy. Front Oncol 2021;11:655325. [PMID: 34136391 DOI: 10.3389/fonc.2021.655325] [Reference Citation Analysis]
156 Peponi E, Skloupiotis V, Tsironis D, Tasiou I, Capizzello A, Tsironis C, Tsimoyiannis KE, Pitouli E, Tsimoyiannis E, Tsekeris P. Preoperative Chemoradiation in Locally Advanced Rectal Cancer: Efficacy and Safety. Gastroenterology Res 2015;8:303-8. [PMID: 27785313 DOI: 10.14740/gr681w] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
157 Ding H, Li J, Chen Y, Yang Z, Peng Z, Liao X. Anal function and quality of life analysis after laparoscopic modified Parks for ultra-low rectal cancer patients. World J Surg Oncol 2020;18:28. [PMID: 32013992 DOI: 10.1186/s12957-020-1801-7] [Reference Citation Analysis]
158 Berardi R, Maccaroni E, Onofri A, Morgese F, Torniai M, Tiberi M, Ferrini C, Cascinu S. Locally advanced rectal cancer: The importance of a multidisciplinary approach. World J Gastroenterol 2014; 20(46): 17279-17287 [PMID: 25516638 DOI: 10.3748/wjg.v20.i46.17279] [Cited by in CrossRef: 18] [Cited by in F6Publishing: 19] [Article Influence: 2.6] [Reference Citation Analysis]
159 Peltrini R, Sacco M, Luglio G, Bucci L. Local excision following chemoradiotherapy in T2-T3 rectal cancer: current status and critical appraisal. Updates Surg 2020;72:29-37. [PMID: 31621033 DOI: 10.1007/s13304-019-00689-2] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 4.0] [Reference Citation Analysis]
160 Grosek J, Velenik V, Edhemovic I, Omejc M. The Influence of the Distal Resection Margin Length on Local Recurrence and long- term Survival in Patients with Rectal Cancer after Chemoradiotherapy and Sphincter- Preserving Rectal Resection. Radiol Oncol 2017;51:169-77. [PMID: 28740452 DOI: 10.1515/raon-2016-0030] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
161 López-Campos F, Martín-Martín M, Fornell-Pérez R, García-Pérez JC, Die-Trill J, Fuentes-Mateos R, López-Durán S, Domínguez-Rullán J, Ferreiro R, Riquelme-Oliveira A, Hervás-Morón A, Couñago F. Watch and wait approach in rectal cancer: Current controversies and future directions. World J Gastroenterol 2020; 26(29): 4218-4239 [PMID: 32848330 DOI: 10.3748/wjg.v26.i29.4218] [Cited by in CrossRef: 13] [Cited by in F6Publishing: 5] [Article Influence: 13.0] [Reference Citation Analysis]
162 Jeong DH, Lee HB, Hur H, Min BS, Baik SH, Kim NK. Optimal timing of surgery after neoadjuvant chemoradiation therapy in locally advanced rectal cancer. J Korean Surg Soc 2013;84:338-45. [PMID: 23741691 DOI: 10.4174/jkss.2013.84.6.338] [Cited by in Crossref: 20] [Cited by in F6Publishing: 23] [Article Influence: 2.5] [Reference Citation Analysis]
163 Watanabe T, Itabashi M, Shimada Y, Tanaka S, Ito Y, Ajioka Y, Hamaguchi T, Hyodo I, Igarashi M, Ishida H, Ishihara S, Ishiguro M, Kanemitsu Y, Kokudo N, Muro K, Ochiai A, Oguchi M, Ohkura Y, Saito Y, Sakai Y, Ueno H, Yoshino T, Boku N, Fujimori T, Koinuma N, Morita T, Nishimura G, Sakata Y, Takahashi K, Tsuruta O, Yamaguchi T, Yoshida M, Yamaguchi N, Kotake K, Sugihara K; Japanese Society for Cancer of the Colon and Rectum. Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer. Int J Clin Oncol. 2015;20:207-239. [PMID: 25782566 DOI: 10.1007/s10147-015-0801-z] [Cited by in Crossref: 379] [Cited by in F6Publishing: 362] [Article Influence: 63.2] [Reference Citation Analysis]
164 Rombouts AJM, Al-Najami I, Abbott NL, Appelt A, Baatrup G, Bach S, Bhangu A, Garm Spindler KL, Gray R, Handley K, Kaur M, Kerkhof E, Kronborg CJ, Magill L, Marijnen CAM, Nagtegaal ID, Nyvang L, Peters FP, Pfeiffer P, Punt C, Quirke P, Sebag-Montefiore D, Teo M, West N, de Wilt JHW; for STAR-TREC Collaborative Group. Can we Save the rectum by watchful waiting or TransAnal microsurgery following (chemo) Radiotherapy versus Total mesorectal excision for early REctal Cancer (STAR-TREC study)?: protocol for a multicentre, randomised feasibility study. BMJ Open. 2017;7:e019474. [PMID: 29288190 DOI: 10.1136/bmjopen-2017-019474] [Cited by in Crossref: 41] [Cited by in F6Publishing: 31] [Article Influence: 10.3] [Reference Citation Analysis]
165 Lee JH, Chie EK, Kim K, Jeong SY, Park KJ, Park JG, Kang GH, Han SW, Oh DY, Im SA, Kim TY, Bang YJ, Ha SW. The influence of the treatment response on the impact of resection margin status after preoperative chemoradiotherapy in locally advanced rectal cancer. BMC Cancer 2013;13:576. [PMID: 24304825 DOI: 10.1186/1471-2407-13-576] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.4] [Reference Citation Analysis]
166 Wu L, Pang S, Yao Q, Jian C, Lin P, Feng F, Li H, Li Y. Population-based study of effectiveness of neoadjuvant radiotherapy on survival in US rectal cancer patients according to age. Sci Rep 2017;7:3471. [PMID: 28615639 DOI: 10.1038/s41598-017-02992-7] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.3] [Reference Citation Analysis]
167 Antunes JT, Ofshteyn A, Bera K, Wang EY, Brady JT, Willis JE, Friedman KA, Marderstein EL, Kalady MF, Stein SL, Purysko AS, Paspulati R, Gollamudi J, Madabhushi A, Viswanath SE. Radiomic Features of Primary Rectal Cancers on Baseline T2 -Weighted MRI Are Associated With Pathologic Complete Response to Neoadjuvant Chemoradiation: A Multisite Study. J Magn Reson Imaging. 2020;52:1531-1541. [PMID: 32216127 DOI: 10.1002/jmri.27140] [Cited by in Crossref: 17] [Cited by in F6Publishing: 15] [Article Influence: 17.0] [Reference Citation Analysis]
168 Park Y, Kim K, Park HJ, Jeong SY, Park KJ, Han SW, Kim TY, Chie EK. Results of re-irradiation for pelvic recurrence in anorectal cancer patients. Br J Radiol 2019;92:20180794. [PMID: 30864822 DOI: 10.1259/bjr.20180794] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
169 Güllülü Ö, Hehlgans S, Rödel C, Fokas E, Rödel F. Tumor Suppressor Protein p53 and Inhibitor of Apoptosis Proteins in Colorectal Cancer-A Promising Signaling Network for Therapeutic Interventions. Cancers (Basel) 2021;13:624. [PMID: 33557398 DOI: 10.3390/cancers13040624] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
170 Yamada K, Murayama Y, Kamada Y, Arita T, Kosuga T, Konishi H, Morimura R, Shiozaki A, Kuriu Y, Ikoma H, Kubota T, Nakanishi M, Fujiwara H, Okamoto K, Otsuji E. Radiosensitizing effect of 5-aminolevulinic acid in colorectal cancer in vitro and in vivo. Oncol Lett 2019;17:5132-8. [PMID: 31186727 DOI: 10.3892/ol.2019.10198] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 3.5] [Reference Citation Analysis]
171 Habr-Gama A, São Julião GP, Mattacheo A, de Campos-Lobato LF, Aleman E, Vailati BB, Gama-Rodrigues J, Perez RO. Extralevator Abdominal Perineal Excision Versus Standard Abdominal Perineal Excision: Impact on Quality of the Resected Specimen and Postoperative Morbidity. World J Surg 2017;41:2160-7. [PMID: 28265736 DOI: 10.1007/s00268-017-3963-1] [Cited by in Crossref: 17] [Cited by in F6Publishing: 14] [Article Influence: 5.7] [Reference Citation Analysis]
172 Jiao G, Huang Q, Hu M, Liang X, Li F, Lan C, Fu W, An Y, Xu B, Zhou J, Xiao J. Therapeutic Suppression of miR-4261 Attenuates Colorectal Cancer by Targeting MCC. Mol Ther Nucleic Acids 2017;8:36-45. [PMID: 28918036 DOI: 10.1016/j.omtn.2017.05.010] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
173 Zhu K, Zhao Q, Yue J, Shi P, Yan H, Xu X, Wang R. GOLPH3 overexpression correlates with poor response to neoadjuvant therapy and prognosis in locally advanced rectal cancer. Oncotarget 2016;7:68328-38. [PMID: 27634904 DOI: 10.18632/oncotarget.12008] [Cited by in Crossref: 11] [Cited by in F6Publishing: 13] [Article Influence: 3.7] [Reference Citation Analysis]
174 Treder M, Vogelsang RP, Janssen S, Schild SE, Holländer NH, Rades D. Potential Prognostic Factors of Downstaging Following Preoperative Chemoradiation for High Rectal Cancer. In Vivo 2018;32:1481-4. [PMID: 30348705 DOI: 10.21873/invivo.11403] [Reference Citation Analysis]
175 Farid M, Lee MJ, Chew MH, Ong WS, Sairi AN, Foo KF, Choo SP, Koo WH, Ong S, Koh PK, Quek R. Localized gastrointestinal stromal tumor of the rectum: An uncommon primary site with prominent disease and treatment-related morbidities. Mol Clin Oncol 2013;1:190-4. [PMID: 24649146 DOI: 10.3892/mco.2012.25] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 0.9] [Reference Citation Analysis]
176 Pang X, Wang F, Zhang Q, Li Y, Huang R, Yin X, Fan X. A Pipeline for Predicting the Treatment Response of Neoadjuvant Chemoradiotherapy for Locally Advanced Rectal Cancer Using Single MRI Modality: Combining Deep Segmentation Network and Radiomics Analysis Based on "Suspicious Region". Front Oncol 2021;11:711747. [PMID: 34422664 DOI: 10.3389/fonc.2021.711747] [Reference Citation Analysis]
177 Kim CH, Lee SY, Kim HR, Kim YJ. Prognostic Effect of Pretreatment Serum Carcinoembryonic Antigen Level: A Useful Tool for Prediction of Distant Metastasis in Locally Advanced Rectal Cancer Following Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision. Medicine (Baltimore) 2015;94:e1291. [PMID: 26252304 DOI: 10.1097/MD.0000000000001291] [Cited by in Crossref: 10] [Cited by in F6Publishing: 6] [Article Influence: 1.7] [Reference Citation Analysis]
178 Caramés C, Cristobal I, Moreno V, Marín JP, González-Alonso P, Torrejón B, Minguez P, Leon A, Martín JI, Hernández R, Pedregal M, Martín MJ, Cortés D, García-Olmo D, Fernández MJ, Rojo F, García-Foncillas J. MicroRNA-31 Emerges as a Predictive Biomarker of Pathological Response and Outcome in Locally Advanced Rectal Cancer. Int J Mol Sci 2016;17:E878. [PMID: 27271609 DOI: 10.3390/ijms17060878] [Cited by in Crossref: 15] [Cited by in F6Publishing: 16] [Article Influence: 3.0] [Reference Citation Analysis]
179 Hogan J, Samaha G, Burke J, Chang KH, Condon E, Waldron D, Coffey JC. Emergency presenting colon cancer is an independent predictor of adverse disease-free survival. Int Surg. 2015;100:77-86. [PMID: 25594643 DOI: 10.9738/intsurg-d-13-00281.1] [Cited by in Crossref: 22] [Cited by in F6Publishing: 7] [Article Influence: 4.4] [Reference Citation Analysis]
180 Song SH, Park JS, Kang MK, Choi GS, Park SY, Kim HJ, Kim JG, Kang BW, Baek JH, Baek DW, Kim JC, Park SH, Cho SH, Seo AN. Initial experience of preoperative short-course radiotherapy followed by oxaliplatin-based consolidation chemotherapy for locally advanced rectal cancer. Int J Colorectal Dis 2021;36:1279-86. [PMID: 33547945 DOI: 10.1007/s00384-021-03875-0] [Reference Citation Analysis]
181 Greystoke A, Mullamitha SA. How many diseases are colorectal cancer? Gastroenterol Res Pract 2012;2012:564741. [PMID: 22991509 DOI: 10.1155/2012/564741] [Cited by in F6Publishing: 20] [Reference Citation Analysis]
182 Tan HH, Thomas NF, Inayat-Hussain SH, Chan KM. Cytoprotective effects of (E)-N-(2-(3, 5-dimethoxystyryl) phenyl) furan-2-carboxamide (BK3C231) against 4-nitroquinoline 1-oxide-induced damage in CCD-18Co human colon fibroblast cells. PLoS One 2020;15:e0223344. [PMID: 32365104 DOI: 10.1371/journal.pone.0223344] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
183 Nakamura T, Sato T, Hayakawa K, Koizumi W, Kumagai Y, Watanabe M. Strategy to avoid local recurrence in patients with locally advanced rectal cancer. Radiat Oncol 2019;14:53. [PMID: 30917848 DOI: 10.1186/s13014-019-1253-9] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
184 Huh JW, Maeda K, Liu Z, Wang X, Roslani AC, Lee WY. Current Status of "Watch-and-Wait" Rectal Cancer Treatment in Asia-Pacific Countries. Ann Coloproctol 2020;36:70-7. [PMID: 32054250 DOI: 10.3393/ac.2020.01.19] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
185 Audisio RA, Papamichael D. Treatment of colorectal cancer in older patients. Nat Rev Gastroenterol Hepatol. 2012;9:716-725. [PMID: 23045000 DOI: 10.1038/nrgastro.2012.196] [Cited by in Crossref: 31] [Cited by in F6Publishing: 27] [Article Influence: 3.4] [Reference Citation Analysis]
186 Räsänen M, Renkonen-Sinisalo L, Mustonen H, Lepistö A. Is there a need for neoadjuvant short-course radiotherapy in T3 rectal cancer with positive lymph node involvement? A single-center retrospective cohort study. World J Surg Oncol 2019;17:139. [PMID: 31395058 DOI: 10.1186/s12957-019-1670-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
187 Abraha I, Aristei C, Palumbo I, Lupattelli M, Trastulli S, Cirocchi R, De Florio R, Valentini V. Preoperative radiotherapy and curative surgery for the management of localised rectal carcinoma. Cochrane Database Syst Rev. 2018;10:CD002102. [PMID: 30284239 DOI: 10.1002/14651858.cd002102.pub3] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
188 Sole CV, Calvo FA, Ferrer C, Alvarez E, Carreras JL, Ochoa E. Human cytomegalovirus and Epstein-Barr virus infection impact on (18)F-FDG PET/CT SUVmax, CT volumetric and KRAS-based parameters of patients with locally advanced rectal cancer treated with neoadjuvant therapy. Eur J Nucl Med Mol Imaging. 2015;42:186-196. [PMID: 25269837 DOI: 10.1007/s00259-014-2910-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 0.9] [Reference Citation Analysis]
189 Liapi A, Mavrantonis C, Lazaridis P, Kourkouni E, Zevlas A, Zografos G, Theodoropoulos G. Validation and comparative assessment of low anterior resection syndrome questionnaires in Greek rectal cancer patients. Ann Gastroenterol 2019;32:185-92. [PMID: 30837792 DOI: 10.20524/aog.2019.0350] [Cited by in Crossref: 2] [Cited by in F6Publishing: 5] [Article Influence: 1.0] [Reference Citation Analysis]
190 McGee SF, AlGhareeb W, Ahmad CH, Armstrong D, Babak S, Berry S, Biagi J, Booth C, Bossé D, Champion P, Colwell B, Finn N, Goel R, Gray S, Green J, Harb M, Hyde A, Jeyakumar A, Jonker D, Kanagaratnam S, Kavan P, MacMillan A, Muinuddin A, Patil N, Porter G, Powell E, Ramjeesingh R, Raza M, Rorke S, Seal M, Servidio-Italiano F, Siddiqui J, Simms J, Smithson L, Snow S, St-Hilaire E, Stuckless T, Tate A, Tehfe M, Thirlwell M, Tsvetkova E, Valdes M, Vickers M, Virik K, Welch S, Marginean C, Asmis T. Eastern Canadian Colorectal Cancer Consensus Conference 2017. Curr Oncol 2018;25:262-74. [PMID: 30111967 DOI: 10.3747/co.25.4083] [Cited by in F6Publishing: 2] [Reference Citation Analysis]
191 Cercek A, Goodman KA, Hajj C, Weisberger E, Segal NH, Reidy-Lagunes DL, Stadler ZK, Wu AJ, Weiser MR, Paty PB, Guillem JG, Nash GM, Temple LK, Garcia-Aguilar J, Saltz LB. Neoadjuvant chemotherapy first, followed by chemoradiation and then surgery, in the management of locally advanced rectal cancer. J Natl Compr Canc Netw. 2014;12:513-519. [PMID: 24717570 DOI: 10.6004/jnccn.2014.0056] [Cited by in Crossref: 121] [Cited by in F6Publishing: 97] [Article Influence: 17.3] [Reference Citation Analysis]
192 Flanagan L, Kehoe J, Fay J, Bacon O, Lindner AU, Kay EW, Deasy J, McNamara DA, Prehn JH. High levels of X-linked Inhibitor-of-Apoptosis Protein (XIAP) are indicative of radio chemotherapy resistance in rectal cancer. Radiat Oncol 2015;10:131. [PMID: 26071313 DOI: 10.1186/s13014-015-0437-1] [Cited by in Crossref: 38] [Cited by in F6Publishing: 33] [Article Influence: 6.3] [Reference Citation Analysis]
193 Zhang Y, Gao Q, Wu Y, Peng Y, Zhuang J, Yang Y, Jiang W, Liu X, Guan G. Hypermethylation and Downregulation of UTP6 Are Associated With Stemness Properties, Chemoradiotherapy Resistance, and Prognosis in Rectal Cancer: A Co-expression Network Analysis. Front Cell Dev Biol 2021;9:607782. [PMID: 34485268 DOI: 10.3389/fcell.2021.607782] [Reference Citation Analysis]
194 Yoo RN, Cho HM, Kye BH, Kim HJ, Shin S, Kim G. Rapid transit in the left-sided colon is related to poor defecatory function at early period after stoma closure. Sci Rep 2020;10:3739. [PMID: 32111913 DOI: 10.1038/s41598-020-60808-7] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
195 Leroi N, Sounni NE, Van Overmeire E, Blacher S, Marée R, Van Ginderachter J, Lallemand F, Lenaerts E, Coucke P, Noel A, Martinive P. The timing of surgery after neoadjuvant radiotherapy influences tumor dissemination in a preclinical model. Oncotarget 2015;6:36825-37. [PMID: 26440148 DOI: 10.18632/oncotarget.5931] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
196 Kulu Y, Hackert T, Debus J, Weber MA, Büchler MW, Ulrich A. [Role of neoadjuvant radiotherapy for rectal cancer : Is MRI-based selection a future model?]. Chirurg 2016;87:573-8. [PMID: 27339645 DOI: 10.1007/s00104-016-0236-8] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 0.6] [Reference Citation Analysis]
197 Yoo RN, Kim HJ. Total neoadjuvant therapy in locally advanced rectal cancer: Role of systemic chemotherapy. Ann Gastroenterol Surg. 2019;3:356-367. [PMID: 31346574 DOI: 10.1002/ags3.12253] [Cited by in Crossref: 11] [Cited by in F6Publishing: 11] [Article Influence: 5.5] [Reference Citation Analysis]
198 Wang T, Wang J, Deng Y, Wu X, Wang L. Neoadjuvant therapy followed by local excision and two-stage total mesorectal excision: a new strategy for sphincter preservation in locally advanced ultra-low rectal cancer. Gastroenterol Rep (Oxf) 2014;2:37-43. [PMID: 24760235 DOI: 10.1093/gastro/got040] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
199 Pan HD, Zhao G, An Q, Xiao G. Pulmonary metastasis in rectal cancer: a retrospective study of clinicopathological characteristics of 404 patients in Chinese cohort. BMJ Open 2018;8:e019614. [PMID: 29455167 DOI: 10.1136/bmjopen-2017-019614] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.7] [Reference Citation Analysis]
200 Osterlund P, Salminen T, Soveri LM, Kallio R, Kellokumpu I, Lamminmäki A, Halonen P, Ristamäki R, Lantto E, Uutela A, Osterlund E, Ovissi A, Nordin A, Heervä E, Lehtomäki K, Räsänen J, Murashev M, Aroviita L, Jekunen A, Lindvall-Andersson R, Nyandoto P, Kononen J, Lepistö A, Poussa T, Muhonen T, Ålgars A, Isoniemi H; Members of The RAXO study group are collaborators of this study and are listed in Appendix Table 4B. Repeated centralized multidisciplinary team assessment of resectability, clinical behavior, and outcomes in 1086 Finnish metastatic colorectal cancer patients (RAXO): A nationwide prospective intervention study. Lancet Reg Health Eur 2021;3:100049. [PMID: 34557799 DOI: 10.1016/j.lanepe.2021.100049] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
201 Fu XL, Fang Z, Shu LH, Tao GQ, Wang JQ, Rui ZL, Zhang YJ, Tian ZQ. Meta-analysis of oxaliplatin-based versus fluorouracil-based neoadjuvant chemoradiotherapy and adjuvant chemotherapy for locally advanced rectal cancer. Oncotarget 2017;8:34340-51. [PMID: 28423720 DOI: 10.18632/oncotarget.16127] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
202 Sakai K, Kazama S, Nagai Y, Murono K, Tanaka T, Ishihara S, Sunami E, Tomida S, Nishio K, Watanabe T. Chemoradiation provides a physiological selective pressure that increases the expansion of aberrant TP53 tumor variants in residual rectal cancerous regions. Oncotarget 2014;5:9641-9. [PMID: 25275295 DOI: 10.18632/oncotarget.2438] [Cited by in Crossref: 20] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
203 Cooper AB, Tzeng CW, Katz MH. Treatment of borderline resectable pancreatic cancer. Curr Treat Options Oncol. 2013;14:293-310. [PMID: 23793524 DOI: 10.1007/s11864-013-0244-6] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
204 Park IJ, An S, Kim SY, Lim HM, Hong SM, Kim MJ, Kim YJ, Yu CS. Prediction of radio-responsiveness with immune-profiling in patients with rectal cancer. Oncotarget 2017;8:79793-802. [PMID: 29108360 DOI: 10.18632/oncotarget.19558] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
205 van den Ende RPJ, Peters FP, Harderwijk E, Rütten H, Bouwmans L, Berbee M, Canters RAM, Stoian G, Compagner K, Rozema T, de Smet M, Intven MPW, Tijssen RHN, Theuws J, van Haaren P, van Triest B, Eekhout D, Marijnen CAM, van der Heide UA, Kerkhof EM. Radiotherapy quality assurance for mesorectum treatment planning within the multi-center phase II STAR-TReC trial: Dutch results. Radiat Oncol 2020;15:41. [PMID: 32070386 DOI: 10.1186/s13014-020-01487-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
206 Junginger T, Maurer CA, Ruppert R, Ptok H, Strassburg J. Comment on the editorial of Sautter-Bihl et al. in Strahlentherapie und Onkologie 2013 189:105-110. Strahlenther Onkol 2013;189:697-9. [PMID: 23700208 DOI: 10.1007/s00066-013-0353-y] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.1] [Reference Citation Analysis]
207 Park JS, Sakai Y, Simon NSM, Law WL, Kim HR, Oh JH, Shan HCY, Kwak SG, Choi GS. Long-Term Survival and Local Relapse Following Surgery Without Radiotherapy for Locally Advanced Upper Rectal Cancer: An International Multi-Institutional Study. Medicine (Baltimore) 2016;95:e2990. [PMID: 27258487 DOI: 10.1097/MD.0000000000002990] [Cited by in Crossref: 16] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
208 Li Q, Dai W, Li Y, Xu Y, Li X, Cai S. Nomograms for predicting the prognostic value of serological tumor biomarkers in colorectal cancer patients after radical resection. Sci Rep 2017;7:46345. [PMID: 28417967 DOI: 10.1038/srep46345] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 2.3] [Reference Citation Analysis]
209 Sassen S, de Booij M, Sosef M, Berendsen R, Lammering G, Clarijs R, Bakker M, Beets-Tan R, Warmerdam F, Vliegen R. Locally advanced rectal cancer: is diffusion weighted MRI helpful for the identification of complete responders (ypT0N0) after neoadjuvant chemoradiation therapy? Eur Radiol 2013;23:3440-9. [PMID: 23832319 DOI: 10.1007/s00330-013-2956-1] [Cited by in Crossref: 50] [Cited by in F6Publishing: 42] [Article Influence: 6.3] [Reference Citation Analysis]
210 Song L, Yin J. Application of Texture Analysis Based on Sagittal Fat-Suppression and Oblique Axial T2-Weighted Magnetic Resonance Imaging to Identify Lymph Node Invasion Status of Rectal Cancer. Front Oncol 2020;10:1364. [PMID: 32850437 DOI: 10.3389/fonc.2020.01364] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 8.0] [Reference Citation Analysis]
211 Kim MJ, Jeong SY, Park JW, Ryoo SB, Cho SS, Lee KY, Park KJ. Oncologic Outcomes in Patients Who Undergo Neoadjuvant Chemoradiotherapy and Total Mesorectal Excision for Locally Advanced Rectal Cancer: A 14-Year Experience in a Single Institution.Ann Coloproctol. 2019;35:83-93. [PMID: 31113173 DOI: 10.3393/ac.2019.04.22.1] [Cited by in Crossref: 5] [Cited by in F6Publishing: 7] [Article Influence: 2.5] [Reference Citation Analysis]
212 Claassen YHM, Vermeer NCA, Iversen LH, van Eycken E, Guren MG, Mroczkowski P, Martling A, Codina Cazador A, Johansson R, Vandendael T, Wibe A, Moller B, Lippert H, Rutten HJT, Portielje JEA, Liefers GJ, Holman FA, van de Velde CJH, Bastiaannet E. Treatment and survival of rectal cancer patients over the age of 80 years: a EURECCA international comparison. Br J Cancer 2018;119:517-22. [PMID: 30057408 DOI: 10.1038/s41416-018-0215-6] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 5.0] [Reference Citation Analysis]
213 Oki E, Ando K, Kasagi Y, Zaitsu Y, Sugiyama M, Nakashima Y, Sonoda H, Ohgaki K, Saeki H, Maehara Y. Recent advances in multidisciplinary approach for rectal cancer. Int J Clin Oncol 2015;20:641-9. [PMID: 26100273 DOI: 10.1007/s10147-015-0858-8] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 0.7] [Reference Citation Analysis]
214 Bisceglia G, Mastrodonato N, Tardio B, Mazzoccoli G, Corsa P, Troiano M, Parisi S. Intermediate neoadjuvant radiotherapy for T3 low/middle rectal cancer: postoperative outcomes of a non-controlled clinical trial. Oncotarget 2014;5:11143-53. [PMID: 25373926 DOI: 10.18632/oncotarget.2603] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.3] [Reference Citation Analysis]
215 Moslim MA, Bastawrous AL, Jeyarajah DR. Neoadjuvant Pelvic Radiotherapy in the Management of Rectal Cancer with Synchronous Liver Metastases: Is It Worth It? J Gastrointest Surg 2021. [PMID: 34100244 DOI: 10.1007/s11605-021-05042-w] [Reference Citation Analysis]
216 Jia X, Xie P, Bi L, Meng X, Wang Z, Hong N, Wang Y. MRI-defined high-risk rectal cancer patients: outcome comparison between neoadjuvant chemoradiotherapy plus TME and TME plus adjuvant chemotherapy or TME alone. Br J Radiol 2021;94:20201221. [PMID: 33591799 DOI: 10.1259/bjr.20201221] [Reference Citation Analysis]
217 Baird DLH, Simillis C, Pellino G, Kontovounisios C, Rasheed S, Tekkis PP. The obesity paradox in beyond total mesorectal excision surgery for locally advanced and recurrent rectal cancer. Updates Surg 2019;71:313-21. [PMID: 30790208 DOI: 10.1007/s13304-019-00631-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 2.5] [Reference Citation Analysis]
218 Wan JF, Zhu J, Li GC, Sun WJ, Zhang Z. Implications for determining the optimal treatment for locally advanced rectal cancer in elderly patients aged 75 years and older. Oncotarget 2015;6:30377-83. [PMID: 26160846 DOI: 10.18632/oncotarget.4599] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.4] [Reference Citation Analysis]
219 Hu LB, Chen Y, Meng XD, Yu P, He X, Li J. Nucleotide Excision Repair Factor XPC Ameliorates Prognosis by Increasing the Susceptibility of Human Colorectal Cancer to Chemotherapy and Ionizing Radiation. Front Oncol 2018;8:290. [PMID: 30109214 DOI: 10.3389/fonc.2018.00290] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 2.7] [Reference Citation Analysis]
220 Shiratori H, Kawai K, Okada M, Nozawa H, Hata K, Tanaka T, Nishikawa T, Shuno Y, Sasaki K, Kaneko M, Murono K, Emoto S, Ishii H, Sonoda H, Ushiku T, Ishihara S. Metastatic role of mammalian target of rapamycin signaling activation by chemoradiotherapy in advanced rectal cancer. Cancer Sci 2020;111:1291-302. [PMID: 31997546 DOI: 10.1111/cas.14332] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
221 Sautter-Bihl ML, Hohenberger W, Fietkau R, Rödel C, Schmidberger H, Sauer R. Rectal cancer : when is the local recurrence risk low enough to refrain from the aim to prevent it? Strahlenther Onkol 2013;189:105-10. [PMID: 23299826 DOI: 10.1007/s00066-012-0299-5] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.1] [Reference Citation Analysis]
222 Lee J, Kwon J, Kim D, Park M, Kim K, Bae I, Kim H, Kong J, Kim Y, Shin U, Kim E. Gene Expression Profiles Associated with Radio-Responsiveness in Locally Advanced Rectal Cancer. Biology (Basel) 2021;10:500. [PMID: 34205090 DOI: 10.3390/biology10060500] [Reference Citation Analysis]
223 Fusco R, Petrillo M, Granata V, Filice S, Sansone M, Catalano O, Petrillo A. Magnetic Resonance Imaging Evaluation in Neoadjuvant Therapy of Locally Advanced Rectal Cancer: A Systematic Review. Radiol Oncol 2017;51:252-62. [PMID: 28959161 DOI: 10.1515/raon-2017-0032] [Cited by in Crossref: 20] [Cited by in F6Publishing: 18] [Article Influence: 5.0] [Reference Citation Analysis]
224 Peters FP, Teo MTW, Appelt AL, Bach S, Baatrup G, de Wilt JHW, Jensenius Kronborg C, Garm Spindler KL, Marijnen CAM, Sebag-Montefiore D. Mesorectal radiotherapy for early stage rectal cancer: A novel target volume. Clin Transl Radiat Oncol 2020;21:104-11. [PMID: 32099912 DOI: 10.1016/j.ctro.2020.02.001] [Cited by in Crossref: 4] [Article Influence: 4.0] [Reference Citation Analysis]
225 Park S, Kim NK. The Role of Robotic Surgery for Rectal Cancer: Overcoming Technical Challenges in Laparoscopic Surgery by Advanced Techniques. J Korean Med Sci. 2015;30:837-846. [PMID: 26130943 DOI: 10.3346/jkms.2015.30.7.837] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 3.0] [Reference Citation Analysis]
226 Benard A, Zeestraten EC, Goossens-Beumer IJ, Putter H, van de Velde CJ, Hoon DS, Kuppen PJ. DNA methylation of apoptosis genes in rectal cancer predicts patient survival and tumor recurrence. Apoptosis 2014;19:1581-93. [PMID: 25064172 DOI: 10.1007/s10495-014-1022-z] [Cited by in Crossref: 12] [Cited by in F6Publishing: 11] [Article Influence: 2.0] [Reference Citation Analysis]
227 Sammour T, Chang GJ. Lateral pelvic lymph node dissection and radiation treatment for rectal cancer: Mutually exclusive or mutually beneficial? Ann Gastroenterol Surg 2018;2:348-50. [PMID: 30238075 DOI: 10.1002/ags3.12197] [Cited by in Crossref: 18] [Cited by in F6Publishing: 16] [Article Influence: 6.0] [Reference Citation Analysis]
228 Sole CV, Calvo FA, Alvarez E, Peligros I, Garcia-Alfonso P, Ferrer C, Ochoa E, Herranz R, Carreras JL. Clinical significance of VEGFR-2 and ¹⁸F-FDG PET/CT SUVmax pretreatment score in predicting the long-term outcome of patients with locally advanced rectal cancer treated with neoadjuvant therapy. Eur J Nucl Med Mol Imaging 2013;40:1635-44. [PMID: 23801169 DOI: 10.1007/s00259-013-2479-7] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
229 Timaner M, Bril R, Kaidar-Person O, Rachman-Tzemah C, Alishekevitz D, Kotsofruk R, Miller V, Nevelsky A, Daniel S, Raviv Z, Rotenberg SA, Shaked Y. Dequalinium blocks macrophage-induced metastasis following local radiation. Oncotarget 2015;6:27537-54. [PMID: 26348470 DOI: 10.18632/oncotarget.4826] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 4.2] [Reference Citation Analysis]
230 Abdel-Rahman O, Elhalawani HM, Allen PK, Holliday EB. Utilization of short-course radiation therapy for patients with nonmetastatic rectal adenocarcinoma in the United States. Adv Radiat Oncol 2018;3:611-20. [PMID: 30370362 DOI: 10.1016/j.adro.2018.07.007] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
231 Chang BW, Kumar AM, Koyfman SA, Kalady M, Lavery I, Abdel-Wahab M. Radiation therapy in patients with inflammatory bowel disease and colorectal cancer: risks and benefits. Int J Colorectal Dis 2015;30:403-8. [PMID: 25564345 DOI: 10.1007/s00384-014-2103-8] [Cited by in Crossref: 13] [Cited by in F6Publishing: 12] [Article Influence: 2.2] [Reference Citation Analysis]
232 Yeo SG, Kim DY. An update on preoperative radiotherapy for locally advanced rectal cancer. J Korean Soc Coloproctol 2012;28:179-87. [PMID: 22993703 DOI: 10.3393/jksc.2012.28.4.179] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 0.6] [Reference Citation Analysis]
233 Huang B, Mo S, Zhu L, Xu T, Cai G. The survival and clinicopathological differences between patients with stage IIIA and stage II rectal cancer: An analysis of 12,036 patients in the SEER database. Oncotarget 2016;7:79787-96. [PMID: 27806332 DOI: 10.18632/oncotarget.12970] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 2.7] [Reference Citation Analysis]
234 Yu Z, Zhang C, Chai R, Du Y, Gao X, Xing J, Yu E, Zhang W, Zhang X, Cao G, Fu C. Prognostic significance and molecular mechanism of ATP-binding cassette subfamily C member 4 in resistance to neoadjuvant radiotherapy of locally advanced rectal carcinoma. PLoS One 2014;9:e85446. [PMID: 24454870 DOI: 10.1371/journal.pone.0085446] [Cited by in Crossref: 7] [Cited by in F6Publishing: 8] [Article Influence: 1.0] [Reference Citation Analysis]
235 Sun Y, Zhang Y, Huang Z, Chi P. Prognostic Implication of Negative Lymph Node Count in ypN+ Rectal Cancer after Neoadjuvant Chemoradiotherapy and Construction of a Prediction Nomogram. J Gastrointest Surg. 2019;23:1006-1014. [PMID: 30187336 DOI: 10.1007/s11605-018-3942-3] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
236 Kim WR, Han YD, Cho MS, Hur H, Min BS, Lee KY, Kim NK. Oncologic Impact of Fewer Than 12 Lymph Nodes in Patients Who Underwent Neoadjuvant Chemoradiation Followed by Total Mesorectal Excision for Locally Advanced Rectal Cancer. Medicine94:e1133. [PMID: 26181550 DOI: 10.1097/md.0000000000001133] [Cited by in Crossref: 7] [Cited by in F6Publishing: 5] [Article Influence: 1.2] [Reference Citation Analysis]
237 de Vries NL, Swets M, Vahrmeijer AL, Hokland M, Kuppen PJ. The Immunogenicity of Colorectal Cancer in Relation to Tumor Development and Treatment. Int J Mol Sci 2016;17:E1030. [PMID: 27367680 DOI: 10.3390/ijms17071030] [Cited by in Crossref: 23] [Cited by in F6Publishing: 21] [Article Influence: 4.6] [Reference Citation Analysis]
238 Zhong W, Xue X, Dai L, Li R, Nie K, Zhou S. Neoadjuvant treatments for resectable rectal cancer: A network meta-analysis. Exp Ther Med 2020;19:2604-14. [PMID: 32256740 DOI: 10.3892/etm.2020.8494] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
239 Fung-Kee-Fung SD. Therapeutic approaches in the management of locally advanced rectal cancer. J Gastrointest Oncol 2014;5:353-61. [PMID: 25276408 DOI: 10.3978/j.issn.2078-6891.2014.067] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
240 Honda M, Oba K, Akiyoshi T, Maeda H, Kashiwabara K, Kanda M, Mayanagi S, Aoyama T, Hamada C, Sadahiro S, Fukunaga Y, Ueno M, Sakamoto J, Saji S, Yoshikawa T. Development and validation of a prognostic nomogram for colorectal cancer after radical resection based on individual patient data from three large-scale phase III trials. Oncotarget 2017;8:99150-60. [PMID: 29228760 DOI: 10.18632/oncotarget.21845] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
241 Wei XL, Qiu MZ, Zhou YX, He MM, Luo HY, Wang FH, Zhang DS, Li YH, Xu RH. The clinicopathologic relevance and prognostic value of tumor deposits and the applicability of N1c category in rectal cancer with preoperative radiotherapy. Oncotarget 2016;7:75094-103. [PMID: 27655707 DOI: 10.18632/oncotarget.12058] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 4.0] [Reference Citation Analysis]
242 Häfner MF, Debus J. Radiotherapy for Colorectal Cancer: Current Standards and Future Perspectives. Visc Med 2016;32:172-7. [PMID: 27493944 DOI: 10.1159/000446486] [Cited by in Crossref: 26] [Cited by in F6Publishing: 22] [Article Influence: 5.2] [Reference Citation Analysis]
243 Cao W, Wu L, Zhao Y, Zhou J, Li W, Wang X, Xu J, Zhou Z, Liang C. A New MRI-Defined Biomarker for Rectal Mucinous Adenocarcinoma: Mucin Pool Patterns in Determining the Efficacy of Neoadjuvant Therapy. Front Oncol 2020;10:1425. [PMID: 32974154 DOI: 10.3389/fonc.2020.01425] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
244 Sun Y, Zhang Y, Huang Z, Lin H, Lu X, Huang Y, Chi P. Combination of Preoperative Plasma Fibrinogen and Neutrophil-to-Lymphocyte Ratio (the F-NLR Score) as a Prognostic Marker of Locally Advanced Rectal Cancer Following Preoperative Chemoradiotherapy. World J Surg 2020;44:1975-84. [PMID: 32020327 DOI: 10.1007/s00268-020-05407-3] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 8.0] [Reference Citation Analysis]
245 Binefa G, Rodríguez-Moranta F, Teule &, Medina-Hayas M. Colorectal cancer: From prevention to personalized medicine. World J Gastroenterol 2014; 20(22): 6786-6808 [PMID: 24944469 DOI: 10.3748/wjg.v20.i22.6786] [Cited by in CrossRef: 155] [Cited by in F6Publishing: 145] [Article Influence: 22.1] [Reference Citation Analysis]
246 Hendren S, McKeown E, Morris AM, Wong SL, Oerline M, Poe L, Campbell DA Jr, Birkmeyer NJ. Implementation of a hospital-based quality assessment program for rectal cancer. J Oncol Pract 2014;10:e120-9. [PMID: 24839288 DOI: 10.1200/JOP.2014.001387] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.3] [Reference Citation Analysis]
247 Kim MJ, Kim ES, Yeo SG. Definitive high-dose radiotherapy with concurrent chemotherapy for locally advanced rectal cancer: A case report and literature review. Medicine (Baltimore) 2016;95:e5059. [PMID: 27749573 DOI: 10.1097/MD.0000000000005059] [Cited by in Crossref: 4] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
248 Roeder F, Meldolesi E, Gerum S, Valentini V, Rödel C. Recent advances in (chemo-)radiation therapy for rectal cancer: a comprehensive review. Radiat Oncol 2020;15:262. [PMID: 33172475 DOI: 10.1186/s13014-020-01695-0] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 3.0] [Reference Citation Analysis]
249 Lim DR, Bae SU, Hur H, Min BS, Baik SH, Lee KY, Kim NK. Long-term oncological outcomes of robotic versus laparoscopic total mesorectal excision of mid-low rectal cancer following neoadjuvant chemoradiation therapy. Surg Endosc 2017;31:1728-37. [PMID: 27631313 DOI: 10.1007/s00464-016-5165-6] [Cited by in Crossref: 39] [Cited by in F6Publishing: 29] [Article Influence: 7.8] [Reference Citation Analysis]
250 Meng Y, Zhang C, Zou S, Zhao X, Xu K, Zhang H, Zhou C. MRI texture analysis in predicting treatment response to neoadjuvant chemoradiotherapy in rectal cancer. Oncotarget. 2018;9:11999-12008. [PMID: 29552288 DOI: 10.18632/oncotarget.23813] [Cited by in Crossref: 21] [Cited by in F6Publishing: 20] [Article Influence: 5.3] [Reference Citation Analysis]
251 Lavanchy JL, Vaisnora L, Haltmeier T, Zlobec I, Brügger LE, Candinas D, Schnüriger B. Oncologic long-term outcomes of emergency versus elective resection for colorectal cancer. Int J Colorectal Dis 2019;34:2091-9. [PMID: 31709491 DOI: 10.1007/s00384-019-03426-8] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
252 Roeder F. Neoadjuvant radiotherapeutic strategies in pancreatic cancer. World J Gastrointest Oncol 2016; 8(2): 186-197 [PMID: 26909133 DOI: 10.4251/wjgo.v8.i2.186] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
253 Wong AC, Stock S, Schrag D, Kahn KL, Salz T, Charlton ME, Rogers SO Jr, Goodman KA, Keating NL. Physicians' beliefs about the benefits and risks of adjuvant therapies for stage II and stage III colorectal cancer. J Oncol Pract 2014;10:e360-7. [PMID: 24986112 DOI: 10.1200/JOP.2013.001309] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 0.9] [Reference Citation Analysis]
254 Yang R, Guan X, Liu E, Wei R, Zhao Z, Chen H, Liu Z, Yang M, Jiang Z, Wang X. Risk and Prognosis of Secondary Rectal Cancer After Radiation Therapy for Pelvic Cancer. Front Oncol 2020;10:584072. [PMID: 33194727 DOI: 10.3389/fonc.2020.584072] [Reference Citation Analysis]
255 Sturiale A, Martellucci J, Zurli L, Vaccaro C, Brusciano L, Limongelli P, Docimo L, Valeri A. Long-term functional follow-up after anterior rectal resection for cancer. Int J Colorectal Dis. 2017;32:83-88. [PMID: 27695976 DOI: 10.1007/s00384-016-2659-6] [Cited by in Crossref: 36] [Cited by in F6Publishing: 27] [Article Influence: 7.2] [Reference Citation Analysis]
256 Garcia-Aguilar J, Renfro LA, Chow OS, Shi Q, Carrero XW, Lynn PB, Thomas CR Jr, Chan E, Cataldo PA, Marcet JE, Medich DS, Johnson CS, Oommen SC, Wolff BG, Pigazzi A, McNevin SM, Pons RK, Bleday R. Organ preservation for clinical T2N0 distal rectal cancer using neoadjuvant chemoradiotherapy and local excision (ACOSOG Z6041): results of an open-label, single-arm, multi-institutional, phase 2 trial. Lancet Oncol 2015;16:1537-46. [PMID: 26474521 DOI: 10.1016/S1470-2045(15)00215-6] [Cited by in Crossref: 203] [Cited by in F6Publishing: 69] [Article Influence: 33.8] [Reference Citation Analysis]
257 Petresc B, Lebovici A, Caraiani C, Feier DS, Graur F, Buruian MM. Pre-Treatment T2-WI Based Radiomics Features for Prediction of Locally Advanced Rectal Cancer Non-Response to Neoadjuvant Chemoradiotherapy: A Preliminary Study. Cancers (Basel) 2020;12:E1894. [PMID: 32674345 DOI: 10.3390/cancers12071894] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
258 Thompson EV, Bleier JI. Transanal Minimally Invasive Surgery. Clin Colon Rectal Surg. 2017;30:112-119. [PMID: 28381942 DOI: 10.1055/s-0036-1597315] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 3.0] [Reference Citation Analysis]
259 Wertzberger BE, Sherman SK, Byrn JC. Differences in short-term outcomes among patients undergoing IPAA with or without preoperative radiation: a National Surgical Quality Improvement Program analysis. Dis Colon Rectum 2014;57:1188-94. [PMID: 25203375 DOI: 10.1097/DCR.0000000000000206] [Cited by in Crossref: 10] [Cited by in F6Publishing: 3] [Article Influence: 1.4] [Reference Citation Analysis]
260 Yang C, Jiang ZK, Liu LH, Zeng MS. Pre-treatment ADC image-based random forest classifier for identifying resistant rectal adenocarcinoma to neoadjuvant chemoradiotherapy. Int J Colorectal Dis. 2020;35:101-107. [PMID: 31786652 DOI: 10.1007/s00384-019-03455-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
261 Miwa K, Oki E, Enomoto M, Ihara K, Ando K, Fujita F, Tominaga M, Mori S, Nakayama G, Shimokawa M, Saeki H, Baba H, Mori M, Akagi Y. Randomized phase II study comparing the efficacy and safety of SOX versus mFOLFOX6 as neoadjuvant chemotherapy without radiotherapy for locally advanced rectal cancer (KSCC1301). BMC Cancer 2021;21:23. [PMID: 33402130 DOI: 10.1186/s12885-020-07766-5] [Reference Citation Analysis]
262 Qaderi SM, Galjart B, Verhoef C, Slooter GD, Koopman M, Verhoeven RHA, de Wilt JHW, van Erning FN. Disease recurrence after colorectal cancer surgery in the modern era: a population-based study. Int J Colorectal Dis 2021. [PMID: 33813606 DOI: 10.1007/s00384-021-03914-w] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
263 Fields EC, Kaplan BJ, Karlin J, Myers JL, Mukhopadhyay N, Deng X, Sankala H, Grossman SR, Matin K. Phase 1 Study of Neoadjuvant Short-Course Radiation Therapy Concurrent With Infusional 5-Fluorouracil for the Treatment of Locally Advanced Rectal Cancer. Adv Radiat Oncol 2019;4:605-12. [PMID: 31673654 DOI: 10.1016/j.adro.2019.04.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
264 Frydrych LM, Ulintz P, Bankhead A, Sifuentes C, Greenson J, Maguire L, Irwin R, Fearon ER, Hardiman KM. Rectal cancer sub-clones respond differentially to neoadjuvant therapy. Neoplasia 2019;21:1051-62. [PMID: 31521947 DOI: 10.1016/j.neo.2019.08.004] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]
265 González-Flores E, Losa F, Pericay C, Polo E, Roselló S, Safont MJ, Vera R, Aparicio J, Cano MT, Fernández-Martos C. SEOM Clinical Guideline of localized rectal cancer (2016). Clin Transl Oncol 2016;18:1163-71. [PMID: 27905053 DOI: 10.1007/s12094-016-1591-0] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
266 Millard T, Kunk PR, Ramsdale E, Rahma OE. Current debate in the oncologic management of rectal cancer. World J Gastrointest Oncol 2016; 8(10): 715-724 [PMID: 27795811 DOI: 10.4251/wjgo.v8.i10.715] [Cited by in CrossRef: 5] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
267 AlSaeed EF, Tunio M, Zubaidi A, Al-Obaid O, Ahmed AK, Al-Omar OA, Abid EA, Alsiwat MJ. Five-year outcomes of preoperative chemoradiation for rectal carcinoma in Saudi population: single-institutional experience. Ann Saudi Med. 2015;35:23-30. [PMID: 26142934 DOI: 10.5144/0256-4947.2015.23] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 0.2] [Reference Citation Analysis]
268 Maspero M, Tyyger MD, Tijssen RHN, Seevinck PR, Intven MPW, van den Berg CAT. Feasibility of magnetic resonance imaging-only rectum radiotherapy with a commercial synthetic computed tomography generation solution. Phys Imaging Radiat Oncol 2018;7:58-64. [PMID: 33458406 DOI: 10.1016/j.phro.2018.09.002] [Cited by in Crossref: 12] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
269 Vignali A, Nardi PD. Multidisciplinary treatment of rectal cancer in 2014: Where are we going? World J Gastroenterol 2014; 20(32): 11249-11261 [PMID: 25170209 DOI: 10.3748/wjg.v20.i32.11249] [Cited by in CrossRef: 12] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
270 Ronnekleiv-Kelly SM, Nukaya M, Díaz-Díaz CJ, Megna BW, Carney PR, Geiger PG, Kennedy GD. Aryl hydrocarbon receptor-dependent apoptotic cell death induced by the flavonoid chrysin in human colorectal cancer cells. Cancer Lett 2016;370:91-9. [PMID: 26515162 DOI: 10.1016/j.canlet.2015.10.014] [Cited by in Crossref: 37] [Cited by in F6Publishing: 29] [Article Influence: 6.2] [Reference Citation Analysis]
271 Tang Z, Liu L, Liu D, Wu L, Lu K, Zhou N, Shen J, Chen G, Liu G. Clinical Outcomes and Safety of Different Treatment Modes for Local Recurrence of Rectal Cancer. Cancer Manag Res 2020;12:12277-86. [PMID: 33299348 DOI: 10.2147/CMAR.S278427] [Reference Citation Analysis]
272 Roeder F. Radiation Therapy in Adult Soft Tissue Sarcoma-Current Knowledge and Future Directions: A Review and Expert Opinion. Cancers (Basel) 2020;12:E3242. [PMID: 33153100 DOI: 10.3390/cancers12113242] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
273 Lin H, Wang L, Zhong X, Zhang X, Shao L, Wu J. Meta-analysis of neoadjuvant chemotherapy versus neoadjuvant chemoradiotherapy for locally advanced rectal cancer. World J Surg Oncol 2021;19:141. [PMID: 33952287 DOI: 10.1186/s12957-021-02251-0] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
274 Youssef FF, Parikh PJ, DeWees TA, Mutch MG, Tan BR Jr, Grigsby PW, Myerson RJ, Olsen JR. Efficacy and toxicity of rectal cancer reirradiation using IMRT for patients who have received prior pelvic radiation therapy. Adv Radiat Oncol 2016;1:94-100. [PMID: 28740875 DOI: 10.1016/j.adro.2016.02.002] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 1.6] [Reference Citation Analysis]
275 Kaytan-Saglam E, Balik E, Saglam S, Akgün Z, Ibis K, Keskin M, Dagoglu N, Kapran Y, Gulluoglu M. Delayed versus immediate surgery following short-course neoadjuvant radiotherapy in resectable (T3N0/N+) rectal cancer. J Cancer Res Clin Oncol 2017;143:1597-603. [PMID: 28374169 DOI: 10.1007/s00432-017-2406-6] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.5] [Reference Citation Analysis]
276 Li YJ, Wang L, Sun TT, Wu AW. Laparoscopy-assisted transanal total mesorectal excision for lower rectal cancer: A feasible and innovative technique. World J Gastrointest Oncol 2021; 13(1): 12-23 [PMID: 33510846 DOI: 10.4251/wjgo.v13.i1.12] [Reference Citation Analysis]
277 Sun Q, Liu T, Liu P, Luo J, Zhang N, Lu K, Ju H, Zhu Y, Wu W, Zhang L, Fan Y, Liu Y, Li D, Zhu Y, Liu L. Perineural and lymphovascular invasion predicts for poor prognosis in locally advanced rectal cancer after neoadjuvant chemoradiotherapy and surgery. J Cancer. 2019;10:2243-2249. [PMID: 31258728 DOI: 10.7150/jca.31473] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 3.0] [Reference Citation Analysis]
278 Narayanan S, Attwood K, Gabriel E, Nurkin S. Pathologic Complete Response Despite Nodal Yield Has Best Survival in Locally Advanced Rectal Cancer. J Surg Res 2020;251:220-7. [PMID: 32172008 DOI: 10.1016/j.jss.2020.01.019] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
279 Cai G, Zhu J, Palmer JD, Xu Y, Hu W, Gu W, Cai S, Zhang Z. CAPIRI-IMRT: a phase II study of concurrent capecitabine and irinotecan with intensity-modulated radiation therapy for the treatment of recurrent rectal cancer. Radiat Oncol 2015;10:57. [PMID: 25889149 DOI: 10.1186/s13014-015-0360-5] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 2.0] [Reference Citation Analysis]
280 Dewdney A, Cunningham D, Chau I. Selecting patients with locally advanced rectal cancer for neoadjuvant treatment strategies. Oncologist. 2013;18:833-842. [PMID: 23821325 DOI: 10.1634/theoncologist.2013-0022] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 1.3] [Reference Citation Analysis]
281 Zheng C, Jiang F, Lin H, Li S. Clinical characteristics and prognosis of different primary tumor location in colorectal cancer: a population-based cohort study. Clin Transl Oncol 2019;21:1524-31. [PMID: 30875062 DOI: 10.1007/s12094-019-02083-1] [Cited by in Crossref: 10] [Cited by in F6Publishing: 11] [Article Influence: 5.0] [Reference Citation Analysis]
282 Cai G, Zhu J, Hu W, Zhang Z. Accelerated hyperfractionated intensity-modulated radiotherapy for recurrent/unresectable rectal cancer in patients with previous pelvic irradiation: results of a phase II study. Radiat Oncol 2014;9:278. [PMID: 25497847 DOI: 10.1186/s13014-014-0278-3] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
283 Creavin B, Ryan E, Martin ST, Hanly A, O'Connell PR, Sheahan K, Winter DC. Organ preservation with local excision or active surveillance following chemoradiotherapy for rectal cancer. Br J Cancer. 2017;116:169-174. [PMID: 27997526 DOI: 10.1038/bjc.2016.417] [Cited by in Crossref: 52] [Cited by in F6Publishing: 41] [Article Influence: 10.4] [Reference Citation Analysis]
284 Baltodano PA, Reinhardt ME, Flores JM, Abreu FM, Chattha A, Kone L, Cooney CM, Manahan MA, Zellars RC, Rosson GD. Preoperative Radiotherapy Is Not Associated with Increased Post-mastectomy Short-term Morbidity: Analysis of 77,902 Patients. Plast Reconstr Surg Glob Open 2017;5:e1108. [PMID: 28458959 DOI: 10.1097/GOX.0000000000001108] [Cited by in Crossref: 4] [Article Influence: 1.0] [Reference Citation Analysis]
285 Glynne-Jones R, Hava N, Goh V, Bosompem S, Bridgewater J, Chau I, Gaya A, Wasan H, Moran B, Melcher L, MacDonald A, Osborne M, Beare S, Jitlal M, Lopes A, Hall M, West N, Quirke P, Wong WL, Harrison M;  Bacchus investigators. Bevacizumab and Combination Chemotherapy in rectal cancer Until Surgery (BACCHUS): a phase II, multicentre, open-label, randomised study of neoadjuvant chemotherapy alone in patients with high-risk cancer of the rectum. BMC Cancer. 2015;15:764. [PMID: 26493588 DOI: 10.1186/s12885-015-1764-1] [Cited by in Crossref: 19] [Cited by in F6Publishing: 20] [Article Influence: 3.2] [Reference Citation Analysis]
286 Meng X, Wang R, Huang Z, Zhang J, Feng R, Xu X, Zhu K, Dou X, Chen D, Yu J. Human epidermal growth factor receptor-2 expression in locally advanced rectal cancer: association with response to neoadjuvant therapy and prognosis. Cancer Sci 2014;105:818-24. [PMID: 24730770 DOI: 10.1111/cas.12421] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 1.3] [Reference Citation Analysis]
287 Shang Y, Wang L, Zhu Z, Gao W, Li D, Zhou Z, Chen L, Fu CG. Downregulation of miR-423-5p Contributes to the Radioresistance in Colorectal Cancer Cells. Front Oncol 2020;10:582239. [PMID: 33505907 DOI: 10.3389/fonc.2020.582239] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
288 Thompson MK, Poortmans P, Chalmers AJ, Faivre-Finn C, Hall E, Huddart RA, Lievens Y, Sebag-Montefiore D, Coles CE. Practice-changing radiation therapy trials for the treatment of cancer: where are we 150 years after the birth of Marie Curie? Br J Cancer 2018;119:389-407. [PMID: 30061587 DOI: 10.1038/s41416-018-0201-z] [Cited by in Crossref: 49] [Cited by in F6Publishing: 42] [Article Influence: 16.3] [Reference Citation Analysis]
289 Yamashita H, Ishihara S, Nozawa H, Kawai K, Kiyomatsu T, Okuma K, Abe O, Watanabe T, Nakagawa K. Comparison of volumetric-modulated arc therapy using simultaneous integrated boosts (SIB-VMAT) of 45 Gy/55 Gy in 25 fractions with conventional radiotherapy in preoperative chemoradiation for rectal cancers: a propensity score case-matched analysis. Radiat Oncol 2017;12:156. [PMID: 28934968 DOI: 10.1186/s13014-017-0894-9] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 1.5] [Reference Citation Analysis]
290 AlGizawy SM, Essa HH, Ahmed BM. Chemotherapy Alone for Patients With Stage II/III Rectal Cancer Undergoing Radical Surgery. Oncologist 2015;20:752-7. [PMID: 26040621 DOI: 10.1634/theoncologist.2015-0038] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
291 Chen YT, Huang CW, Ma CJ, Tsai HL, Yeh YS, Su WC, Chai CY, Wang JY. An observational study of patho-oncological outcomes of various surgical methods in total mesorectal excision for rectal cancer: a single center analysis. BMC Surg 2020;20:23. [PMID: 32013990 DOI: 10.1186/s12893-020-0687-1] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
292 Whitley MJ, Weissleder R, Kirsch DG. Tailoring Adjuvant Radiation Therapy by Intraoperative Imaging to Detect Residual Cancer. Semin Radiat Oncol 2015;25:313-21. [PMID: 26384279 DOI: 10.1016/j.semradonc.2015.05.005] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 1.0] [Reference Citation Analysis]
293 Habr-Gama A, São Julião GP, Vailati BB, Castro I, Raffaele D. Management of the Complete Clinical Response. Clin Colon Rectal Surg 2017;30:387-94. [PMID: 29184475 DOI: 10.1055/s-0037-1606116] [Cited by in Crossref: 12] [Cited by in F6Publishing: 9] [Article Influence: 3.0] [Reference Citation Analysis]
294 Kripp M, Merx K, Wirtz RM, Gaiser T, Eidt S, Schwaab J, Post S, Wenz F, Hochhaus A, Hofheinz RD, Erben P. Prognostic Impact of mRNA Expression Levels of HER1-4 (ERBB1-4) in Patients with Locally Advanced Rectal Cancer. Gastroenterol Res Pract 2016;2016:3481578. [PMID: 27610130 DOI: 10.1155/2016/3481578] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
295 Verrijssen AS, Guillem J, Perez R, Bujko K, Guedj N, Habr-Gama A, Houben R, Goudkade D, Melenhorst J, Buijsen J, Vanneste B, Grabsch HI, Bellezzo M, Paiva Fonseca G, Verhaegen F, Berbee M, Van Limbergen EJ. Microscopic intramural extension of rectal cancer after neoadjuvant chemoradiation: A meta-analysis based on individual patient data. Radiother Oncol 2020;144:37-45. [PMID: 31710942 DOI: 10.1016/j.radonc.2019.10.003] [Reference Citation Analysis]
296 Keskin M, Bayraktar A, Sivirikoz E, Yegen G, Karip B, Saglam E, Bulut MT, Balik E. Sparing Sphincters and Laparoscopic Resection Improve Survival by Optimizing the Circumferential Resection Margin in Rectal Cancer Patients. Medicine (Baltimore) 2016;95:e2669. [PMID: 26844498 DOI: 10.1097/MD.0000000000002669] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.4] [Reference Citation Analysis]
297 Nagasaki T, Akiyoshi T, Fujimoto Y, Konishi T, Nagayama S, Fukunaga Y, Ueno M. Preoperative Chemoradiotherapy Might Improve the Prognosis of Patients with Locally Advanced Low Rectal Cancer and Lateral Pelvic Lymph Node Metastases. World J Surg. 2017;41:876-883. [PMID: 27730348 DOI: 10.1007/s00268-016-3748-y] [Cited by in Crossref: 18] [Cited by in F6Publishing: 17] [Article Influence: 4.5] [Reference Citation Analysis]
298 Rana N, Chakravarthy AB, Kachnic LA. Neoadjuvant Treatment for Locally Advanced Rectal Cancer: New Concepts in Clinical Trial Design. Curr Treat Options Oncol. 2017;18:13. [PMID: 28281215 DOI: 10.1007/s11864-017-0454-4] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
299 Yamamoto T, Kawada K, Hida K, Ganeko R, Inamoto S, Yoshitomi M, Watanabe T, Sakai Y. Optimal treatment strategy for rectal cancer based on the risk factors for recurrence patterns. Int J Clin Oncol 2019;24:677-85. [PMID: 30721379 DOI: 10.1007/s10147-019-01400-6] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
300 Chen J, Sun Y, Chi P, Sun B. MRI pelvimetry-based evaluation of surgical difficulty in laparoscopic total mesorectal excision after neoadjuvant chemoradiation for male rectal cancer. Surg Today 2021;51:1144-51. [PMID: 33420827 DOI: 10.1007/s00595-020-02211-3] [Reference Citation Analysis]
301 Yang B, Shan J, Feng Y, Dai N, Li M, Chen C, He S, Wang G, Xiao H, Li C, Wang D. Transcatheter rectal arterial chemoembolization with oxaliplatin plus S-1 concurrent chemoradiotherapy can improve the pathological remission rate in locally advanced rectal cancer: a comparative study. Radiat Oncol 2020;15:94. [PMID: 32375814 DOI: 10.1186/s13014-020-01540-4] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
302 Yoon HI, Koom WS, Kim TH, Ahn JB, Jung M, Kim TI, Kim H, Shin SJ, Kim NK. Upfront Systemic Chemotherapy and Short-Course Radiotherapy with Delayed Surgery for Locally Advanced Rectal Cancer with Distant Metastases: Outcomes, Compliance, and Favorable Prognostic Factors. PLoS One 2016;11:e0161475. [PMID: 27536871 DOI: 10.1371/journal.pone.0161475] [Cited by in Crossref: 16] [Cited by in F6Publishing: 14] [Article Influence: 3.2] [Reference Citation Analysis]
303 Dhruva Rao PK, Peiris SPM, Arif SS, Davies RA, Masoud AG, Haray PN. Value of multi-disciplinary input into laparoscopic management of rectal cancer - An observational study. World J Gastrointest Surg 2017; 9(6): 153-160 [PMID: 28690775 DOI: 10.4240/wjgs.v9.i6.153] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.5] [Reference Citation Analysis]
304 Armbruster M, D'Anastasi M, Holzner V, Kreis ME, Dietrich O, Brandlhuber B, Graser A, Brandlhuber M. Improved detection of a tumorous involvement of the mesorectal fascia and locoregional lymph nodes in locally advanced rectal cancer using DCE-MRI. Int J Colorectal Dis. 2018;33:901-909. [PMID: 29774398 DOI: 10.1007/s00384-018-3083-x] [Cited by in Crossref: 9] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
305 Choi SH, Chang JS, Kim NK, Lim JS, Min BS, Hur H, Shin SJ, Ahn JB, Kim YB, Koom WS. Reduced pelvic field sparing anastomosis for postoperative radiotherapy in selected patients with mid-upper rectal cancer. J Radiat Res 2017;58:559-66. [PMID: 28122969 DOI: 10.1093/jrr/rrw127] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
306 Sun Y, Zhang Y, Wu X, Chi P. A Four Gene-Based Risk Score System Associated with Chemoradiotherapy Response and Tumor Recurrence in Rectal Cancer by Co-Expression Network Analysis. Onco Targets Ther. 2020;13:6721-6733. [PMID: 32753901 DOI: 10.2147/ott.s256696] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
307 Liu Y, Zhang FJ, Zhao XX, Yang Y, Liang CY, Feng LL, Wan XB, Ding Y, Zhang YW. Development of a Joint Prediction Model Based on Both the Radiomics and Clinical Factors for Predicting the Tumor Response to Neoadjuvant Chemoradiotherapy in Patients with Locally Advanced Rectal Cancer. Cancer Manag Res 2021;13:3235-46. [PMID: 33880066 DOI: 10.2147/CMAR.S295317] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
308 Sorrentino L, Guaglio M, Battaglia L, Bonfanti G, Vitellaro M, Bianchi AC, Milione M, Belli F. Neoadjuvant chemo-radiotherapy for cT3N0 rectal cancer: any benefit over upfront surgery? A propensity score-matched study. Int J Colorectal Dis 2019;34:2161-9. [PMID: 31741026 DOI: 10.1007/s00384-019-03446-4] [Reference Citation Analysis]
309 Wang L, Gu GL, Li ZW, Peng YF, Gu J. Abdominoperineal excision following preoperative radiotherapy for rectal cancer: Unfavorable prognosis even with negative circumferential resection margin. World J Gastroenterol 2014; 20(27): 9138-9145 [PMID: 25083087 DOI: 10.3748/wjg.v20.i27.9138] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
310 Hardiman KM, Antunez AG, Kanters A, Schuman AD, Regenbogen SE. Clinical and pathological outcomes of induction chemotherapy before neoadjuvant radiotherapy in locally-advanced rectal cancer. J Surg Oncol 2019;120:308-15. [PMID: 30993710 DOI: 10.1002/jso.25474] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
311 Chiloiro G, Rodriguez-Carnero P, Lenkowicz J, Casà C, Masciocchi C, Boldrini L, Cusumano D, Dinapoli N, Meldolesi E, Carano D, Damiani A, Barbaro B, Manfredi R, Valentini V, Gambacorta MA. Delta Radiomics Can Predict Distant Metastasis in Locally Advanced Rectal Cancer: The Challenge to Personalize the Cure. Front Oncol 2020;10:595012. [PMID: 33344243 DOI: 10.3389/fonc.2020.595012] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 4.0] [Reference Citation Analysis]
312 Fan WH, Wang FL, Lu ZH, Pan ZZ, Li LR, Gao YH, Chen G, Wu XJ, Ding PR, Zeng ZF, Wan DS. Surgery with versus without preoperative concurrent chemoradiotherapy for mid/low rectal cancer: an interim analysis of a prospective, randomized trial.Chin J Cancer. 2015;34:394-403. [PMID: 26111932 DOI: 10.1186/s40880-015-0024-8] [Cited by in Crossref: 8] [Cited by in F6Publishing: 12] [Article Influence: 1.3] [Reference Citation Analysis]
313 Brouquet A, Bachet JB, Huguet F, Karoui M, Artru P, Sabbagh C, Lefèvre JH, Vernerey D, Mariette C, Vicaut E, Benoist S; on behalf the FRENCH , GRECCAR, PRODIGE study groups. NORAD01-GRECCAR16 multicenter phase III non-inferiority randomized trial comparing preoperative modified FOLFIRINOX without irradiation to radiochemotherapy for resectable locally advanced rectal cancer (intergroup FRENCH-GRECCAR- PRODIGE trial). BMC Cancer 2020;20:485. [PMID: 32471382 DOI: 10.1186/s12885-020-06968-1] [Cited by in Crossref: 6] [Cited by in F6Publishing: 5] [Article Influence: 6.0] [Reference Citation Analysis]
314 Wang QX, Li SH, Zhang X, Xie L, Cai PQ, An X, Pan ZZ, Ding PR. Identification of locally advanced rectal cancer with low risk of local recurrence. PLoS One 2015;10:e0117141. [PMID: 25629521 DOI: 10.1371/journal.pone.0117141] [Cited by in Crossref: 7] [Cited by in F6Publishing: 6] [Article Influence: 1.2] [Reference Citation Analysis]
315 Alickikus ZA, Kuru A, Aydin B, Akcay D, Gorken IB. The importance of mesorectum motion in determining PTV margins in rectal cancer patients treated with neoadjuvant radiotherapy. J Radiat Res 2020;61:335-42. [PMID: 31867610 DOI: 10.1093/jrr/rrz092] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
316 Kim SC, Shin YK, Kim YA, Jang SG, Ku JL. Identification of genes inducing resistance to ionizing radiation in human rectal cancer cell lines: re-sensitization of radio-resistant rectal cancer cells through down regulating NDRG1. BMC Cancer 2018;18:594. [PMID: 29801473 DOI: 10.1186/s12885-018-4514-3] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 4.7] [Reference Citation Analysis]
317 Zhang H, Huang Y, Sun G, Zheng K, Lou Z, Gao XH, Hao LQ, Liu LJ, Meng RG, Zhang W. Rectal cancer patients with downstaging after neoadjuvant chemoradiotherapy and radical resection do not benefit from adjuvant chemotherapy. Ann Transl Med 2020;8:743. [PMID: 32647668 DOI: 10.21037/atm-20-1278] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
318 Cristóbal I, Rubio J, Santos A, Torrejón B, Caramés C, Imedio L, Mariblanca S, Luque M, Sanz-Alvarez M, Zazo S, Madoz-Gúrpide J, Rojo F, García-Foncillas J. MicroRNA-199b Downregulation Confers Resistance to 5-Fluorouracil Treatment and Predicts Poor Outcome and Response to Neoadjuvant Chemoradiotherapy in Locally Advanced Rectal Cancer Patients. Cancers (Basel) 2020;12:E1655. [PMID: 32580513 DOI: 10.3390/cancers12061655] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 6.0] [Reference Citation Analysis]
319 Zaghloul MS, Christodouleas JP, Smith A, Abdallah A, William H, Khaled HM, Hwang WT, Baumann BC. Adjuvant Sandwich Chemotherapy Plus Radiotherapy vs Adjuvant Chemotherapy Alone for Locally Advanced Bladder Cancer After Radical Cystectomy: A Randomized Phase 2 Trial. JAMA Surg 2018;153:e174591. [PMID: 29188298 DOI: 10.1001/jamasurg.2017.4591] [Cited by in Crossref: 37] [Cited by in F6Publishing: 31] [Article Influence: 12.3] [Reference Citation Analysis]
320 Lu Z, Cheng P, Zhang MG, Wang XS, Zheng ZX. Is adjuvant chemotherapy necessary for patients with ypT0-2N0 rectal cancer treated with neoadjuvant chemoradiotherapy and curative surgery? Gastroenterol Rep (Oxf) 2018;6:277-83. [PMID: 30430016 DOI: 10.1093/gastro/goy029] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 2.0] [Reference Citation Analysis]
321 Ling Y, Yang L, Huang H, Hu X, Zhao C, Huang H, Ying Y. Prognostic Significance of Statin Use in Colorectal Cancer: A Systematic Review and Meta-Analysis. Medicine (Baltimore). 2015;94:e908. [PMID: 26107680 DOI: 10.1097/md.0000000000000908] [Cited by in Crossref: 24] [Cited by in F6Publishing: 10] [Article Influence: 4.0] [Reference Citation Analysis]
322 Noh JM, Park W, Kim JS, Koom WS, Kim JH, Choi DH, Park HC. Outcome of Local Excision Following Preoperative Chemoradiotherapy for Clinically T2 Distal Rectal Cancer: A Multicenter Retrospective Study (KROG 12-06). Cancer Res Treat 2014;46:243-9. [PMID: 25038759 DOI: 10.4143/crt.2014.46.3.243] [Cited by in Crossref: 19] [Cited by in F6Publishing: 18] [Article Influence: 2.7] [Reference Citation Analysis]
323 Zitt M, DeVries A, Thaler J, Kafka-Ritsch R, Eisterer W, Lukas P, Öfner D. Long-term surveillance of locally advanced rectal cancer patients with neoadjuvant chemoradiation and aggressive surgical treatment of recurrent disease: a consecutive single-centre experience. Int J Colorectal Dis. 2015;30:1705-1714. [PMID: 26293791 DOI: 10.1007/s00384-015-2366-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 3] [Article Influence: 1.0] [Reference Citation Analysis]
324 Yeo SG, Kim MJ, Kim DY, Chang HJ, Kim MJ, Baek JY, Kim SY, Kim TH, Park JW, Oh JH. Patterns of failure in patients with locally advanced rectal cancer receiving pre-operative or post-operative chemoradiotherapy. Radiat Oncol. 2013;8:114. [PMID: 23647920 DOI: 10.1186/1748- 717X-8-114] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
325 Kripp M, Horisberger K, Mai S, Kienle P, Gaiser T, Post S, Wenz F, Merx K, Hofheinz RD. Does the Addition of Cetuximab to Radiochemotherapy Improve Outcome of Patients with Locally Advanced Rectal Cancer? Long-Term Results from Phase II Trials. Gastroenterol Res Pract 2015;2015:273489. [PMID: 25861256 DOI: 10.1155/2015/273489] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 1.7] [Reference Citation Analysis]
326 Plastiras A, Sideris M, Gaya A, Haji A, Nunoo-Mensah J, Haq A, Papagrigoriadis S. Waiting Time following Neoadjuvant Chemoradiotherapy for Rectal Cancer: Does It Really Matter. Gastrointest Tumors 2018;4:96-103. [PMID: 29594111 DOI: 10.1159/000484982] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 0.8] [Reference Citation Analysis]
327 Punt CJ, Koopman M, Vermeulen L. From tumour heterogeneity to advances in precision treatment of colorectal cancer. Nat Rev Clin Oncol. 2017;14:235-246. [PMID: 27922044 DOI: 10.1038/nrclinonc.2016.171] [Cited by in Crossref: 239] [Cited by in F6Publishing: 236] [Article Influence: 47.8] [Reference Citation Analysis]
328 Empuku S, Nakajima K, Akagi T, Kaneko K, Hijiya N, Etoh T, Shiraishi N, Moriyama M, Inomata M. An 80-gene set to predict response to preoperative chemoradiotherapy for rectal cancer by principle component analysis. Mol Clin Oncol 2016;4:733-9. [PMID: 27123272 DOI: 10.3892/mco.2016.806] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.8] [Reference Citation Analysis]
329 Letaief F, Nasri M, Ayadi M, Meddeb K, Mokrani A, Yahyaoui Y, Chraiet N, Raies H, Mezlini A. Potential predictive factors for pathologic complete response after the neoadjuvant treatment of rectal adenocarcinoma: a single center experience. Cancer Biol Med 2017;14:327-34. [PMID: 28884049 DOI: 10.20892/j.issn.2095-3941.2017.0037] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
330 Kuipers EJ, Grady WM, Lieberman D, Seufferlein T, Sung JJ, Boelens PG, van de Velde CJ, Watanabe T. Colorectal cancer. Nat Rev Dis Primers. 2015;1:15065. [PMID: 27189416 DOI: 10.1038/nrdp.2015.65] [Cited by in Crossref: 485] [Cited by in F6Publishing: 482] [Article Influence: 80.8] [Reference Citation Analysis]
331 Martinez-Useros J, Moreno I, Fernandez-Aceñero MJ, Rodriguez-Remirez M, Borrero-Palacios A, Cebrian A, Gomez Del Pulgar T, Del Puerto-Nevado L, Li W, Puime-Otin A, Perez N, Soengas MS, Garcia-Foncillas J. The potential predictive value of DEK expression for neoadjuvant chemoradiotherapy response in locally advanced rectal cancer. BMC Cancer 2018;18:144. [PMID: 29409457 DOI: 10.1186/s12885-018-4048-8] [Cited by in Crossref: 6] [Cited by in F6Publishing: 7] [Article Influence: 2.0] [Reference Citation Analysis]
332 Bernier L, Balyasnikova S, Tait D, Brown G. Watch-and-Wait as a Therapeutic Strategy in Rectal Cancer. Curr Colorectal Cancer Rep. 2018;14:37-55. [PMID: 29576755 DOI: 10.1007/s11888-018-0398-5] [Cited by in Crossref: 30] [Cited by in F6Publishing: 24] [Article Influence: 10.0] [Reference Citation Analysis]
333 Yin JD, Song LR, Lu HC, Zheng X. Prediction of different stages of rectal cancer: Texture analysis based on diffusion-weighted images and apparent diffusion coefficient maps. World J Gastroenterol 2020; 26(17): 2082-2096 [PMID: 32536776 DOI: 10.3748/wjg.v26.i17.2082] [Cited by in CrossRef: 10] [Cited by in F6Publishing: 9] [Article Influence: 10.0] [Reference Citation Analysis]
334 Kye BH, Cho HM. Overview of radiation therapy for treating rectal cancer. Ann Coloproctol 2014;30:165-74. [PMID: 25210685 DOI: 10.3393/ac.2014.30.4.165] [Cited by in Crossref: 32] [Cited by in F6Publishing: 24] [Article Influence: 4.6] [Reference Citation Analysis]
335 丁健华, 张斌. 低位直肠癌经括约肌间保肛手术应用现状. 世界华人消化杂志 2016; 24(26): 3764-3771 [DOI: 10.11569/wcjd.v24.i26.3764] [Reference Citation Analysis]
336 Watanabe T, Muro K, Ajioka Y, Hashiguchi Y, Ito Y, Saito Y, Hamaguchi T, Ishida H, Ishiguro M, Ishihara S, Kanemitsu Y, Kawano H, Kinugasa Y, Kokudo N, Murofushi K, Nakajima T, Oka S, Sakai Y, Tsuji A, Uehara K, Ueno H, Yamazaki K, Yoshida M, Yoshino T, Boku N, Fujimori T, Itabashi M, Koinuma N, Morita T, Nishimura G, Sakata Y, Shimada Y, Takahashi K, Tanaka S, Tsuruta O, Yamaguchi T, Yamaguchi N, Tanaka T, Kotake K, Sugihara K;  Japanese Society for Cancer of the Colon and Rectum. Japanese Society for Cancer of the Colon and Rectum (JSCCR) guidelines 2016 for the treatment of colorectal cancer. Int J Clin Oncol. 2018;23:1-34. [PMID: 28349281 DOI: 10.1007/s10147-017-1101-6] [Cited by in Crossref: 400] [Cited by in F6Publishing: 364] [Article Influence: 100.0] [Reference Citation Analysis]
337 Zheng R, Lian S, Huang X, Guan G, Li X, Chi P, Xu B. The survival benefit of intensified full-dose XELOX chemotherapy concomitant to radiotherapy and then resting-period consolidation chemotherapy in locally advanced rectal cancer. J Cancer 2019;10:730-6. [PMID: 30719172 DOI: 10.7150/jca.28265] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 1.5] [Reference Citation Analysis]
338 Romesser PB, Wu AJ, Cercek A, Smith JJ, Weiser M, Saltz L, Garcia-Aguilar J, Crane CH. Management of Locally Advanced Rectal Cancer During The COVID-19 Pandemic: A Necessary Paradigm Change at Memorial Sloan Kettering Cancer Center. Adv Radiat Oncol. 2020;. [PMID: 32322758 DOI: 10.1016/j.adro.2020.04.011] [Cited by in Crossref: 18] [Cited by in F6Publishing: 14] [Article Influence: 18.0] [Reference Citation Analysis]
339 Tang J, Wu X, Gao Y, Jiang W, Kong L, Lin J, Wan D, Pan Z, Ding P. Long-Term Outcome of Oxaliplatin and Capecitabine (XELOX) Concomitant with Neoadjuvant Radiotherapy and Extended to the Resting Period in High Risk Locally Advanced Rectal Cancer. J Cancer. 2018;9:1365-1370. [PMID: 29721045 DOI: 10.7150/jca.23874] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 1.7] [Reference Citation Analysis]
340 Tabrizi S, Trippa L, Cagney D, Aizer AA, Tanguturi S, Ventz S, Fell G, Bellon JR, Mamon H, Nguyen PL, D'Amico AV, Haas-Kogan D, Alexander BM, Rahman R. Assessment of Simulated SARS-CoV-2 Infection and Mortality Risk Associated With Radiation Therapy Among Patients in 8 Randomized Clinical Trials. JAMA Netw Open 2021;4:e213304. [PMID: 33779742 DOI: 10.1001/jamanetworkopen.2021.3304] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
341 Bökkerink GMJ, van der Wilt GJ, de Jong D, van Krieken HHJM, Bleichrodt RP, de Wilt JHW, Bremers AJA. Value of macrobiopsies and transanal endoscopic microsurgery in the histological work-up of rectal neoplasms: A retrospective study. World J Gastrointest Oncol 2017; 9(6): 251-256 [PMID: 28656075 DOI: 10.4251/wjgo.v9.i6.251] [Cited by in CrossRef: 1] [Article Influence: 0.3] [Reference Citation Analysis]
342 Morris EJ, Finan PJ, Spencer K, Geh I, Crellin A, Quirke P, Thomas JD, Lawton S, Adams R, Sebag-Montefiore D. Wide Variation in the Use of Radiotherapy in the Management of Surgically Treated Rectal Cancer Across the English National Health Service. Clin Oncol (R Coll Radiol) 2016;28:522-31. [PMID: 26936609 DOI: 10.1016/j.clon.2016.02.002] [Cited by in Crossref: 35] [Cited by in F6Publishing: 33] [Article Influence: 7.0] [Reference Citation Analysis]
343 Bogner A, Kirchberg J, Weitz J, Fritzmann J. State of the Art - Rectal Cancer Surgery. Visc Med. 2019;35:252-258. [PMID: 31602388 DOI: 10.1159/000501133] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
344 Kunneman M, Marijnen CA, Rozema T, Ceha HM, Grootenboers DA, Neelis KJ, Stiggelbout AM, Pieterse AH. Decision consultations on preoperative radiotherapy for rectal cancer: large variation in benefits and harms that are addressed. Br J Cancer 2015;112:39-43. [PMID: 25333343 DOI: 10.1038/bjc.2014.546] [Cited by in Crossref: 23] [Cited by in F6Publishing: 19] [Article Influence: 3.3] [Reference Citation Analysis]
345 Skóra T, Nowak-Sadzikowska J, Martynów D, Wszołek M, Sas-Korczyńska B. Preoperative short-course radiotherapy in rectal cancer patients: results and prognostic factors. J Radiat Oncol 2018;7:77-84. [PMID: 29576860 DOI: 10.1007/s13566-017-0340-5] [Cited by in Crossref: 8] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
346 Osti MF, Agolli L, Bracci S, Masoni L, Valeriani M, Falco T, De Sanctis V, Maurizi Enrici R. Neoadjuvant chemoradiation with concomitant boost radiotherapy associated to capecitabine in rectal cancer patients. Int J Colorectal Dis. 2014;29:835-842. [PMID: 24825722 DOI: 10.1007/s00384-014-1879-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 0.6] [Reference Citation Analysis]
347 Bostel T, Dreher C, Wollschläger D, Mayer A, König F, Bickelhaupt S, Schlemmer HP, Huber PE, Sterzing F, Bäumer P, Debus J, Nicolay NH. Exploring MR regression patterns in rectal cancer during neoadjuvant radiochemotherapy with daily T2- and diffusion-weighted MRI. Radiat Oncol 2020;15:171. [PMID: 32653003 DOI: 10.1186/s13014-020-01613-4] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
348 Murimwa G, Hester C, Mansour JC, Polanco PM, Porembka MR, Wang SC, Zeh HJ Jr, Yopp AC. Comparative Outcomes of Adenosquamous Carcinoma of the Gallbladder: an Analysis of the National Cancer Database. J Gastrointest Surg 2021;25:1815-27. [PMID: 32705618 DOI: 10.1007/s11605-020-04729-w] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
349 Chen TY, Emmertsen KJ, Laurberg S. What Are the Best Questionnaires To Capture Anorectal Function After Surgery in Rectal Cancer? Curr Colorectal Cancer Rep 2015;11:37-43. [PMID: 25663833 DOI: 10.1007/s11888-014-0217-6] [Cited by in Crossref: 45] [Cited by in F6Publishing: 40] [Article Influence: 6.4] [Reference Citation Analysis]
350 Wang L, Zhai ZW, Ji DB, Li ZW, Gu J. Prognostic value of CD45RO(+) tumor-infiltrating lymphocytes for locally advanced rectal cancer following 30 Gy/10f neoadjuvant radiotherapy. Int J Colorectal Dis 2015;30:753-60. [PMID: 25935450 DOI: 10.1007/s00384-015-2226-6] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 1.7] [Reference Citation Analysis]
351 Käser SA, Froelicher J, Li Q, Müller S, Metzger U, Castiglione M, Laffer UT, Maurer CA. Adenocarcinomas of the upper third of the rectum and the rectosigmoid junction seem to have similar prognosis as colon cancers even without radiotherapy, SAKK 40/87. Langenbecks Arch Surg 2015;400:675-82. [PMID: 25163656 DOI: 10.1007/s00423-014-1243-1] [Cited by in Crossref: 7] [Cited by in F6Publishing: 7] [Article Influence: 1.0] [Reference Citation Analysis]
352 Dijkstra EA, Mul VEM, Hemmer PHJ, Havenga K, Hospers GAP, Muijs CT, van Etten B. Re-Irradiation in Patients with Recurrent Rectal Cancer is Safe and Feasible. Ann Surg Oncol 2021;28:5194-204. [PMID: 34023946 DOI: 10.1245/s10434-021-10070-6] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
353 Caycedo-Marulanda A, Patel S, Merchant S, Brown C. Introduction of new techniques and technologies in surgery: Where is transanal total mesorectal excision today? World J Gastrointest Surg 2020; 12(5): 203-207 [PMID: 32551026 DOI: 10.4240/wjgs.v12.i5.203] [Cited by in CrossRef: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]